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ABSTRACT
Background: Alcohol consumption leads to a variety of different health consequences including
cardiovascular disease, cancer and malnutrition. This malnutrition is in part due to a sub-optimal
diet but also due to the malabsorption of nutrients along the small intestine. Many studies have
shown that ethanol directly decreases nutrient absorption along the small intestine; however, few
studies have investigated the effect of a moderate dose of ethanol on the transmembrane nutrient
co-transporters that line the brush border membrane of the small intestine. The primary fuel
source for the small intestine, glutamine, as well as for the entire body, glucose, are absorbed by
the sodium-dependent nutrient co-transporters: Na-glutamine co-transport (B0AT1) and Naglucose co-transport (SGLT1), respectively. Both B0AT1 and SGLT1 are present in the brush
border membrane of intestinal absorptive villus, but not crypt cells. The effect of moderate
ethanol consumption on B0AT1 and SGLT1 in intestinal epithelial cells is not known. Methods:
Rat intestinal epithelial cells (IEC-18) were exposed to 8.64 mM ethanol over 1, 3, 6, and 12
hours. Sixteen-week-old Sprague Dawley rats were administered an intragastric gavage of 2 g/kg
ethanol over 1, 3, and 6 hours. Sodium-dependent 3H-glutamine and 3H-O-methyl-D-glucose
uptakes were conducted to determine B0AT1 and SGLT1 activities, respectively. Na-K-ATPase
activity was measured as a function of inorganic phosphate release and with 86rubidium uptake.
Protein expression was analyzed by Western blot analysis and immunohistochemical staining.
Results: Ethanol significantly decreased glutamine absorption, glucose absorption and Na-KATPase activity in enterocytes. Kinetic studies showed a decrease in Vmax values for B0AT1 in
vitro, but an increase in Km values for SGLT1 in vitro and in vivo. Western blots and
immunohistochemistry data support these findings. Ethanol did not change Na-H exchange in
vitro. Acetaldehyde alone did not change glutamine or glucose uptake in vitro. Conclusions:
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Moderate ethanol significantly inhibits B0AT1 and SGLT1 in intestinal epithelial cells. This
occurs through two separate mechanisms: B0AT1 is reduced via a decrease in co-transporter
number while SGLT1 is diminished via a decrease in co-transporter affinity for glucose.
Moreover, both B0AT1 and SGLT1 are further inhibited at the intact cellular level secondary to
the decreased sodium-gradient. Overall, glutamine and glucose absorption by enterocytes is
significantly affected by moderate ethanol, which may help describe the onset of alcoholic
malnutrition.
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CHAPTER 1
ETHANOL AND THE SMALL INTESTINE
Many studies have shown that ethanol consumption affects the cellular metabolism,
structure and function of the intestine (Bode and Bode 2003). Considering the intestinal
epithelium is a sensitive barrier to the outside world, more research should be conducted to fully
understand how ethanol affects the cells along the gastrointestinal (GI) tract.
The small intestine
Structure and layers of the small intestine
The digestive system breaks down and absorbs all the dietary nutrients essential for the
sustenance of life. The human small intestine, where the majority of nutrient absorption occurs,
is made up of three segments, the duodenum (10 inches), jejunum (8 feet) and ileum (12 feet).
The human small intestine itself is a tube-like structure that has four general layers: starting at
the lumen, there is the mucosa, the submucosa, the muscularis externa and the serosa (Figure 1).
The mucosa consists of a surface epithelium, lamina propria and muscularis mucosae. The
intestinal epithelium is primarily made up of intestinal absorptive cells, called enterocytes, held
together by cellular junctions, such as tight junctions (TJ), adherens junctions and gap junctions.
While absorbing nutrients, electrolytes and water is the primary function of the intestinal
epithelium, it also secretes digestive enzymes, hormones (Marieb 2014) and functions as a
barrier to exclude harmful substances such as microorganisms, antigens and toxins from entering
the body (Pochini, Scalise et al. 2014). The next layer, the submucosa, consists of connective
tissue including blood vessels. The muscularis externa is composed of smooth muscle for GI
motility and the serosa is the squamous epithelium layer which reduces friction during GI tract
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movement. The layers of the small intestine all work together to form a functioning GI tract
(Figure 1) (Marieb 2014).
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Figure 1: Physiology of the small intestine. The small intestine, located in the abdominal
cavity, is composed of several layers surrounding the lumen including the mucosa, the
submucosa and the serosa. The mucosa contains the intestinal epithelium, which is created from
individual intestinal cells. The structure of the small intestine contains mechanisms of increased
surface area, including the villi and microvilli. Each image is adapted from the following sources
with permission in order (Institute 2001, Campus 2012, Board 2018).
3

Cellular architecture of the small intestine
The small intestine has an incredible amount of surface area exposed to the lumen.
Although this varies by the individual, the human intestine has a surface area of approximately
32 m2, or approximately half the size of a badminton court (Helander and Fandriks 2014). This is
due to a unique intestinal architecture composed of long finger-like projections, called villi, that
protrude into the lumen of the small intestine. Individual villi are formed by a single layer of
intestinal epithelium composed of many different types of cells including but not limited to
absorptive columnar epithelial cells, goblet cells and enteroendocrine cells. Each intestinal
absorptive villus cell, or enterocyte, has plasma membrane projections called microvilli that are
oriented towards the lumen of the intestine (Marieb 2014). The villi and microvilli increase the
surface area of the small intestine by 60 – 120 times! This increases epithelial cell contact with
the intestinal lumen, which allows for greater nutrient absorption (Helander and Fandriks 2014).
At the base of each villi is a section of proliferative cells located in the connective tissue of the
intestine, which is composed of but not limited to Paneth and stem cells, called the intestinal
crypt. The crypt contains the differentiating cell population, which continually divides and
pushes developing enterocytes up from the crypt renewing the villus section of the intestinal
epithelium. Together, the villus and crypt sections of the intestinal epithelium form a functioning
intestinal barrier (Shaker and Rubin 2010).
Brush border membrane (BBM)
Together, microvilli form the BBM on the apical side of the cell, where nutrient
absorption occurs. Nutrients are absorbed passively, through cell membranes, and actively,
through specific proteins called nutrient co-transporters located at the BBM. The BBM expresses
individual nutrient co-transporters which selectively intake essential nutrients like glutamine and
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glucose into enterocytes. In the enterocyte, nutrients can quickly gain access to the mesenteric
vascular system, which is in close proximity due to the lacteals present in the villi structure.
Once in the vascular system, these nutrients can be quickly distributed throughout the body
(Marieb 2014).
Paracellular and transcellular nutrient absorption
In order to acquire nutrition from the diet, molecules must be absorbed across the
intestinal barrier. This movement of nutrients can be transcellular, traveling through the cell, or
paracellular, traveling between cells. Paracellular absorption along the small intestine varies,
with the duodenum having the greatest amount of paracellular movement and the ileum with the
least, based on the cellular junctions between enterocytes. Transcellular absorption is mediated
through individual protein nutrient co-transporters and channels which allow for the selective
movement of nutrients through the cell membrane of enterocytes, through facilitated transport,
secondary active and active transport. These transport processes, in concert, allow for the
absorption of all the essential nutrients the mammalian body requires for proper function
(Karasov 2017).
Active transport
Active transport requires the direct use of energy to move molecules against their
concentration gradient, such as through hydrolyzing adenosine triphosphate (ATP). Secondary
active transport requires the indirect use of energy by another pump, such as the Na-K-ATPase,
to create a favorable sodium gradient across the BBM which a co-transporter can utilize to move
a molecule along with sodium. For instance, sodium-dependent nutrient co-transporters require
the basolateral Na-K-ATPase to hydrolyze ATP to move three sodium ions out of the cell and
two potassium ions into the cell. This creates a low inner sodium gradient in the cell, which the
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secondary active co-transporter uses to move nutrients along its concentration gradient and other
molecules against their concentration gradient. These gradients can be electrochemically based
as well.
Na-K-ATPase
As previously mentioned, the Na-K-ATPase establishes and maintains intracellular
concentrations of sodium and potassium required for secondary active transport processes. The
Na-K-ATPase was first discovered in 1957 by Jens C. Skou (Skou 1957). This pump is
composed of three main protein subunits: α, β, and FXYD (Kaplan 2002, Clausen, Hilbers et al.
2017). These subunits have different isoform expressions in tissues around the body, including
the α1 and β1 subunits in the small intestine (Saha, Manoharan et al. 2015). The α subunit is the
catalytic subunit whereas the β1 subunit is primarily for trafficking the pump to the plasma
membrane (Kaplan 2002). In addition to its ion pumping function, the Na-K-ATPase has been
shown to have a non-enzymatic signaling function specific to the α1 isoform. The binding of the
cardiotonic steroid ouabain to the Na-K-ATPase activates the Src kinase at low concentrations,
which causes the activation of signaling cascades through protein tyrosine phosphorylation
(Tian, Cai et al. 2006). The signaling function has been shown to be critical for cell physiology
(Liang, Tian et al. 2007), transport regulation (Cai, Wu et al. 2008), and sodium flux (Liu, Yan et
al. 2017). In all, the Na-K-ATPase has important roles in cells, both in maintaining the sodium
concentration gradient as well as activating signaling cascades (Clausen, Hilbers et al. 2017).
Types of nutrient co-transporters
There are specific protein nutrient transporters along the intestine to absorb all the
molecules the mammalian body requires. The main transporter families are the ATP binding
cassette family, often efflux transporters, and the solute carrier family (SLC), often uptake
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transporters. The SLC family will be focused on during this dissertation. There is a huge amount
of these transporters, including at least 395 SLC transporters that range in specificity of
substrates. Generally, amino acids are primarily absorbed by the SLC3, 6, 7, 25 and 36 families.
Carbohydrates like glucose, galactose, and fructose are absorbed by the SLC2, 5 and 37 families.
Vitamins are absorbed by SLC19, 25, 46 and 52 whereas metals are absorbed by SLC11, 30, 39
and 40. Polymorphisms in SLC transporters have been identified with various human diseases
including inflammatory bowel disease, jaundice, diabetes, and more. More research is required to
fully understand the relationship between the transporters of the SLC family and different
disease states, such as alcohol-dependent malnutrition (Lin, Yee et al. 2015).
Alcohol use and associated health consequences
Prevalence of alcohol use in the United States
Ethanol, commonly known as alcohol, is prevalently used in the United States. According
to the 2015 National Survey on Drug Use and Health, 86 percent of the United States population
has had alcohol at some point in their lifetime with 56 percent of the population reporting that
they consumed an alcoholic beverage in the past month (NIAAA, Gunzerath, Faden et al. 2004).
Despite its frequent use, alcohol consumption has a fiscal burden on our society. Alcohol
consumption cost the United States an estimated 249 billion dollars in 2010, including but not
limited to increased medical care costs. Overall, alcohol use is very prevalent among the
population of the United States, but its use has significant fiscal and health consequences on our
society.
Health consequences of alcohol use
Alcohol use is the fifth leading cause of premature death in the world and is responsible
for 6 percent of all global deaths as of 2014 (NIAAA). Alcohol use increases risks for a variety
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of different diseases including liver disease, high blood pressure, heart disease, stroke, digestive
issues, and cancer of the breast, mouth, throat, esophagus, liver and colon (NIAAA, Rehm,
Baliunas et al. 2010, Krenz and Korthuis 2012, Roerecke and Rehm 2012, Organization 2018).
Furthermore, heavy alcohol use is associated with weight gain and increased obesity risk, as the
molecule itself contains 7 kcal/g (Traversy and Chaput 2015). In addition to its health risks,
long-term alcohol use also increases risk for societal issues including mental health problems,
lost productivity, and alcohol dependence (Organization 2018).
Definitions of alcohol consumption
Considering the fiscal, social and health risks associated with alcohol use, it is vital to
understand how much alcohol is too much. The National Institute on Alcohol Abuse and
Alcoholism defines moderate drinking as one alcoholic beverage a day for women and up to two
a day for men, with a standard alcoholic beverage considered the equivalent of 14 g of ethanol
(NIAAA, Gunzerath, Faden et al. 2004). One standard alcoholic beverage is equal to 12 fluid
ounces of beer, 5 fluid ounces of wine, or 1.5 fluid ounces of an 80-proof liquor. As opposed to
moderate alcohol consumption, heavy alcohol use is considered eight or more alcoholic
beverages per week for women or 15 or more for men. Binge drinking, another form of heavy
alcohol consumption, is considered four or more alcoholic beverages during a single occasion for
women or five or more for men (Table 1) (Table 2) (NIAAA, Prevention).
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Table 1: Levels of alcohol consumption. One drink refers to one standard alcoholic beverage.
BAC – Blood alcohol content (NIAAA, Prevention).

Table 2: Levels of experimental alcohol consumption. BAC – Blood alcohol content, v/v –
volume by volume, w/v – weight by volume (NIAAA, Prevention).

Benefits of moderate alcohol use
Despite the health risks associated with heavy alcohol consumption, there are some
health benefits to moderate alcohol use. Moderate alcohol use decreases the risk for heart
disease, ischemic stroke (Gunzerath, Faden et al. 2004), diabetes (Yokoyama 2011), and even
obesity (Gunzerath, Faden et al. 2004, Stockwell and Room 2012). These health benefits
9

associated with alcohol consumption stem from any general type of alcoholic beverage (beer,
wine or liquor). The decreased risk for heart disease and myocardial infarction stem from
beneficial changes to blood lipid profile, clotting factors, vasodilation through increased nitric
oxide synthase and more. Moderate alcohol consumption also decreases the risk of type II
diabetes and improves insulin sensitivity, by decreasing gluconeogenesis in the liver leading to
less glucose leaving the liver and protection for the pancreatic cells (Yokoyama 2011, Krenz and
Korthuis 2012).
Interestingly, moderate alcohol use has been linked to a decreased risk for obesity as
well. Moderate consumers of alcohol are less likely to gain weight compared to abstainers
(Wang, Lee et al. 2010, Traversy and Chaput 2015), which is interesting because ethanol itself
contains calories. Furthermore, moderate alcohol use has not been associated with increased
weight gain, adiposity, body mass index, or waist circumference (Gunzerath, Faden et al. 2004,
Traversy and Chaput 2015). In a study with over 8,000 participants, alcohol use was associated
with a lower prevalence of metabolic syndrome (Freiberg, Cabral et al. 2004). The mechanism of
this decreased obesity risk is unknown. However, ethanol has been shown to decrease the
absorption of nutrients along the small intestine which may lead to the decreased risk of obesity
seen with moderate alcohol intake (Bode and Bode 2003).
Alcohol use and risk of mortality
The relationship between ethanol and its beneficial health outcomes has been highly
debated. Previous studies have determined that the relationship between alcohol use and
mortality is J-shaped (Stockwell, Zhao et al. 2016). Initial studies found that those who abstain
from alcohol use have a higher risk of mortality than those who moderately drink, leading to the
curve in the J-shape. Moreover, those who use alcohol heavily have an increased risk of
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mortality, significantly more than those who moderately drink or abstain. However, alcohol
intake over longitudinal studies is difficult to define. There are many variables that can alter the
overall conclusions drawn. The variables associated with alcohol-dependent longitudinal studies
include the dosage of ethanol, frequency of alcohol use, consistent drinking versus episodic
drinking, exercise, diet, sex, and many more. A recent study published by Stockwell and
colleagues discussed how the decreased risk for mortality based on alcohol use is incorrect; more
specifically, the relationship has been inflated due to poorly chosen control groups (Stockwell,
Zhao et al. 2016). For example, underlying health issues may force some subjects to abstain from
alcohol, creating a group of alcohol abstainers who are more unhealthy than moderate drinkers
for reasons other than alcohol consumption. When these unhealthy abstainers are used in
mortality studies, their underlying health issues make the control group more likely to become
ill, which artificially inflates the benefits of moderate alcohol use. After adjusting for what
Stockwell and colleagues determined to be truly comparable abstainers, researchers found that
occasional moderate drinking has no net mortality benefit (Stockwell, Zhao et al. 2016). The
discrepancies found in these mortality studies are important because they may also be true for the
associations between moderate alcohol use and its related health benefits. Clearly, further
research is required to understand the relationship between alcohol use and overall health
outcomes.
To drink or not drink, that is the question
More research needs to be conducted on the possible health benefits or consequences of
moderate alcohol use before a more accurate conclusion can be drawn. The previous health
benefits attained with moderate alcohol use often have supportive in vitro and in vivo data and
current longitudinal studies are now aware of the possible unhealthy abstainer inflation
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associated with these studies. Furthermore, studies have been conducted specifically on moderate
alcohol use and the associated decreased risk for cardiovascular disease, which corrected for this
unhealthy abstainer phenomenon. Researchers found that there was still a significant decrease in
the risk for cardiovascular disease, just not as large of a decreased risk as previously reported (Di
Castelnuovo, Costanzo et al. 2006). Does this mean a glass of wine with dinner is safe?
Unfortunately, this is still unclear. What is known is that any amount of ethanol can increase
cancer risk, even at moderate doses. Overall, it is suggested by the United States Dietary
Guidelines to limit alcohol use. The guidelines also suggest abstainers to not start using alcohol.
Therefore, the question of whether to consume alcohol or not remains convoluted.
Gastrointestinal absorption of ethanol
First pass metabolism of ethanol
Ethanol first interacts with the body through the GI tract. When alcohol is orally
consumed, it undergoes initial metabolism in the stomach. Ethanol metabolism requires ethanol
to be oxidized to acetaldehyde, ethanol’s primary toxic metabolite. This occurs through several
pathways. The predominate pathway for ethanol metabolism is through an enzyme called alcohol
dehydrogenase (ADH). Isoforms ADH1 and ADH3 are present in the stomach. One of the first
papers detailing ethanol absorption along the GI tract was conducted in 1948. Researchers
exposed the stomach of Wistar rats to 5 M ethanol for 20 minutes and showed that the stomach
was permeable to ethanol (Karel and Fleisher 1948). Therefore, the initial metabolism of ethanol
occurs in the stomach, which is referred to as first pass metabolism. First pass metabolism varies
based on many factors. Race, age, sex, exercise, previous alcohol use, genetics, biological
rhythms, gastric emptying rates and food intake all vary the pace of ethanol metabolism,
including first pass metabolism. Therefore, it is important to note that not all ingested ethanol
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moves to the vascular system, as some is partially metabolized in the stomach (Cederbaum
2012).
Ethanol absorption in the small intestine
Ethanol undergoes first pass metabolism in the stomach, but the majority of ingested
ethanol is passively absorbed along the upper section of the small intestine called the duodenum.
Ethanol passively diffuses along its concentration gradient through cell membranes due to the
amphiphilic nature of the molecule. This diffusion rate of ethanol into enterocytes is also
determined by a variety of factors including the concentration of ethanol, gastric emptying rate,
food intake, dosage, blood flow, intestinal motility, and intestinal wall permeability (Mudie,
Amidon et al. 2010, Cederbaum 2012). Nevertheless, the passive diffusion of ethanol is rapid.
Ethanol quickly interacts with cell membranes, in the course of nanoseconds (Patra, Salonen et
al. 2006). After passing through the cell membranes, causing some alterations in the membrane
fluidity of the cell membrane, ethanol can quickly pass into the vascular system where it gains
access to the rest of the body. Ethanol is evenly distributed throughout tissues in the body in
proportion to their water content, excluding fats (Cederbaum 2012).
Measuring ethanol in the intestine
Due to ethanol’s quick absorption into the vascular system at the duodenum, the jejunum
and the ileum of the small intestine are affected by ethanol via the basolateral membrane (BLM)
of enterocytes. Unless extremely high dosages of ethanol are consumed, the jejunum and ileum
of the small intestine should not be exposed to ethanol via the BBM. Since ethanol affects the
ileum through the vasculature, blood alcohol content (BAC) is the most accurate unit of
measurement of ethanol for the lower small intestine (Bode and Bode 2003, Krenz and Korthuis
2012). This idea had been well supported by the literature. For example, there was no difference

13

in gas chromatography-mass spectroscopy analysis and high-performance liquid chromatography
of ethanol molality between the ileum and serum of eight-week-old Sprague Dawley rats fed a
heavy dose of ethanol (5.42% w/v) for eight weeks (Xie, Zhong et al. 2013). Furthermore, a
heavy dose of ethanol (2.75 g/kg) injected intraperitoneally in mice showed mucosal changes.
Specifically, villus cells were damaged especially in the ileum of the small intestine (Lee, Choi
et al. 2014). This means that ethanol had traveled from the vascular system and into the lumen of
the small intestine to cause these disruptions, making BAC the most accurate measurement of
ethanol along the lower small intestine (Bode and Bode 2003, Krenz and Korthuis 2012).
Ethanol’s effect on nutrient absorption
Initial research on ethanol and nutrient absorption
Ethanol’s effect on nutrition and its associated research began with a reasonable question:
why are many chronic alcoholics malnourished (Williams, Pelton et al. 1955)? This question
ignited the initial research between ethanol, nutrition, and the small intestine. The first ethanol
and nutrition studies described the effect of ethanol on everted sacs of the rat small intestine,
where a binge-like dose of ethanol (3% v/v) inhibited the transport of phenylalanine, leucine,
glycine, alanine, methionine, valine and glucose (Chang, Lewis et al. 1967). However, the first
breakthrough in the effect of ethanol on a distinct nutrient co-transporter leading to a disease
state was conducted by Hoyumpa and colleagues in 1975, when this group established that an
intragastric binge-like dose of ethanol (50 to 750 mg/100 g of body weight) negatively affects
the active, not passive, transport of low concentrations of thiamine (vitamin B1) (0.06 – 2 µM
thiamine) in the everted jejunal segments of rats (Hoyumpa, Breen et al. 1975). These initial
studies became one of the first significant papers to make the vital connection between alcohol
use, malnutrition and disease states. The thiamine deficiency described in these initial studies is
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directly linked to Wernicke-Korsakoff syndrome, a syndrome presenting with an altered mental
status including confusion and dementia, ataxia and nystagmus. Although only prevalent in
under 2% of the population, Wernicke-Korsakoff syndrome is more common in chronic alcohol
abusers, malnourished individuals, and at one point, babies whose formula was thiamine
deficient (S Akhouri 2019). The brain atrophy associated with this syndrome is directly caused
by thiamine deficiency, which stems from the effect of ethanol on the thiamine transporter in
chronic alcoholics (Thomson 2000, S Akhouri 2019).
Further research by this group led to a long-term study of a heavy dose of ethanol using a
Lieber DeCarli liquid diet (36% ethanol). The diet brought the BAC of rats to over 0.08% for six
to eight weeks. Interestingly, researchers found that Na-K-ATPase activity and thiamine
transport were unchanged in this long-term study. However, this long-term ethanol diet, in
addition to a binge-like dose of ethanol using an intragastric gavage (250 mg/100 g), leading to
BAC of above 0.19%, decreased serosal thiamine transport and Na-K-ATPase activity. Overall,
researchers determined that acute systemic ethanol may be more important than duration of
exposure regarding thiamine transport (Hoyumpa 1980). At this point, the field of ethanol and
nutrition was fully introduced and now more than fifty years of ethanol and nutrition research
exists, from which the relevant findings are described in the following section.
Ethanol’s effect on carbohydrate, protein and lipid absorption
Chronic alcoholics are commonly malnourished, which may stem from a decrease in
caloric intake, but also from an ethanol-mediated decrease in nutrient absorption at the small
intestine (Bode and Bode 2003). The net absorption of a nutrient solution was analyzed in
chronic alcoholics, without alcohol-dependent malnutrition or other intestinal dysfunctions,
using an intestinal perfusion technique (Pfeiffer, Schmidt et al. 1992). Researchers found that
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chronic ethanol decreased the net absorption of water, carbohydrates, proteins and lipids in the
duodenum, but not the upper jejunum. The duodenum may be more susceptible to nutrient
malabsorption due to increased cellular damage from exposure to higher concentrations of
ethanol present only in the duodenum (Pfeiffer, Schmidt et al. 1992, Bode and Bode 2003).
Ethanol and lipid absorption
Chronic ethanol had biphasic effects on lipid absorption in the small intestine. A
moderate dose of ethanol, 0.75 g/kg over one hour, increased the transport of dietary fat but a
heavy dose of ethanol, 36% ethanol liquid diet for 3 to 4 weeks, inhibited the absorption of
dietary fats in rats (Baraona and Lieber 1975). Similarly, the absorption of arachidonic acid and
linoleic acid was decreased in human jejunal tissue exposed to a heavy dose of ethanol (100 mM)
(Barros, Chen et al. 1990). Decreased fatty acid absorption was also found in the duodenum and
the jejunum of chronic alcoholics (Pfeiffer, Schmidt et al. 1993). Further research is required to
better understand the mechanism behind the altered absorption of lipids in the small intestine
following ethanol exposure.
D-glucose
Chronic ethanol decreases absorption of glucose in in vivo models as well as in humans
(Bode and Bode 2003). The effect of ethanol on sodium-dependent glucose co-transport was
investigated in the jejunum of hamsters (Dinda, Beck et al. 1975). Researchers showed that a
binge-like dose of ethanol (450 mM) decreased intracellular water and intracellular glucose,
suggesting an inhibition of active transport. These researchers determined that the net flux of
sodium did not significantly decrease, suggesting that there may be an additional interference of
the carrier-mediated coupled entrance of glucose and sodium across the BBM. The researchers
went further to describe the effect of ethanol on the serosal and luminal side of the hamsters in
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another study. Researchers found that ethanol on the serosal side had no effect on glucose and
water absorption (Dinda and Beck 1977). Further studies were conducted using jejunal purified
BBM vesicles (BBMV) treated with a binge-like dose of ethanol (1-5% w/v) in hamsters as well
(Dinda and Beck 1981). Ethanol was directly added to the BBMV, which then showed a
decrease in glucose absorption. This process was reversible with several ethanol-free washes.
Overall, these researchers showed that the effect of ethanol on glucose absorption is at the level
of the BBM (Dinda and Beck 1981).
Moreover, ethanol inhibited glucose absorption in the small intestine of rats using a
binge-like dose of 3% ethanol in a perfusion study (Cobb, Van Thiel et al. 1983). This
phenomenon was also investigated in the jejunum of chickens (Yunus, Awad et al. 2011). Using
Ussing chambers, a moderate dose of ethanol decreased active glucose absorption in the
intestinal epithelia (0.33% and 0.66%) (Yunus, Awad et al. 2011). A binge-like dose of ethanol
at 3.5% and 7% in canine jejunal Thirty-Vella loops demonstrated a net decrease of glucose
absorption by 13% and 26% respectively (Money, Petroianu et al. 1990). Serum glucose levels
were unaffected (Money, Petroianu et al. 1990).
Researchers investigated further into the effect of ethanol on glucose absorption at the
BBM. Sprague Dawley rats treated with a heavy dose of ethanol (5% v/v) for 28-32 days
increased the absorption of glucose, whereas incubation of the vesicles with binge-like dose of
ethanol (4% v/v) reduced the absorption of glucose in prepared BBMVs from the jejunum (alBalool and Debnam 1989). Overall, researchers hypothesized that the stimulation of glucose in
the chronic model may be due to a compensatory mechanism (al-Balool and Debnam 1989).
Kinetic studies using rats exposed to chronic ethanol examined the effect on glucose absorption.
This study reported that ethanol reduced the maximal rate of uptake of glucose absorption in
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Wistar rats fed a heavy dose of ethanol (20% v/v) by Ryle’s tube for 40 days via a decrease in
Vmax, not Km (Kaur, Kaur et al. 1995).
Overall, the inhibitory effect of ethanol on sodium-dependent glucose co-transport was
determined in the intestine of hamsters (Dinda, Beck et al. 1975, Dinda and Beck 1977, Dinda
and Beck 1981), rats (Cobb, Van Thiel et al. 1983, al-Balool and Debnam 1989, Kaur, Kaur et al.
1995), chickens (Yunus, Awad et al. 2011), dogs (Money, Petroianu et al. 1990) and humans
(Bode and Bode 2003). Collectively, researchers were able to establish that ethanol affects
glucose absorption at the BBM of the small intestine.
D-xylose
Ethanol either decreases or does not affect xylose absorption in animal and human
models (Bode and Bode 2003). Further research is necessary.
L-leucine
The effect of ethanol on leucine absorption is only present in acutely-treated rats (Bode
and Bode 2003). For example, intestinal absorption of leucine was not inhibited following a
heavy dose of ethanol (20% v/v) in Sprague Dawley rats for 7 weeks (Hajjar, Tomicic et al.
1981) or during 40 days of the same volume of ethanol administered via Ryle’s tube in Wistar
rats (Kaur, Kaur et al. 1995). In another study, four weeks of ethanol did not significantly change
total leucine absorption in the rat small intestine, but ethanol did have differing segmental effects
on the upper jejunum and lower ileum. Specifically, the active uptake of leucine was increased in
the jejunum compared to the ileum in response to ethanol in these rats, but it was not statistically
significant (Martines, Morris et al. 1989). Finally, chronic ethanol did not produce a statistically
significant change in leucine absorption at varying concentrations of leucine using a multiplepass perfusion technique in rats (Carreras, Vazquez et al. 1993). This study showed that chronic
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ethanol dosages, as opposed to acute ethanol dosages, can lead to varying effects of ethanol on
nutrient absorption.
L-glycine and L-alanine
In Xenopus llaevis oocytes treated with a binge-like dose of 200 mM ethanol for three
minutes, ethanol reduced dipeptide transport via the hPepT1 (SLC15A1) transporter (Li, Xu et al.
2008). hPepT1 mainly transports di and tripeptides, but ethanol reduced glycyl-sarcosine
currents by 42% while reducing alanyl-alanine currents by 30% without affecting the affinity of
the co-transporter (Km) (Li, Xu et al. 2008). Furthermore, sodium-dependent glycine absorption
was significantly decreased in Wistar rats administered a heavy 20% v/v dose of ethanol for 40
days (Kaur, Kaur et al. 1995). Overall, researchers demonstrated that ethanol can also directly
affect the transport of peptides in the small intestine as well.
Ethanol’s effect on vitamin absorption
Thiamine (vitamin B1)
Alcohol-dependent thiamine deficiency can lead to Wernicke-Korsakoff syndrome
(Thomson 2000). As previously discussed, ethanol significantly decreases the active transport of
low concentrations of thiamine in the small intestine of rats exposed to chronic ethanol
(Hoyumpa, Breen et al. 1975, Hoyumpa 1980, Bode and Bode 2003). Heavy ethanol
administration for 2, 4, and 6 weeks in male Wistar rats also showed decreased thiamine
transport along the jejunal BBM and BLM at the level of the thiamine transporter. Ethanol
reduced the protein and mRNA expression of thiamin transporter-1, but not thiamine transporter2. Researchers were able to show a corresponding reduction in the thiamine transporter’s
transcriptional promotor activity levels. Furthermore, this phenomenon of decreased thiamine
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transport was also reproducible in human intestinal epithelial HuTu-80 cells (Subramanya,
Subramanian et al. 2010).
Interestingly, there may be some differences in types of alcohol consumed and the
associated effect of ethanol on thiamine transport specifically. In a study conducted in the
jejunum of male Wistar rats, a binge-like dose of 12% v/v ethanol and wine both reduced 3Hthiamine mucosal-to-serosal permeability by approximately 60% using Ussing chambers, but in a
21-day treatment, red wine alone did not cause a decrease in thiamine permeability. Therefore,
the type of ethanol tested in these nutrition studies is important to consider (Lemos, Azevedo et
al. 2005). Overall, ethanol-mediated thiamine deficiency occurs at the level of the thiamine
transporter and can be reproduced in humans which is important due to its direct causation of
Wernicke-Korsakoff syndrome (Thomson 2000, S Akhouri 2019).
Folate (vitamin B9)
Folate deficiency during pregnancy can lead to developmental deformities including in
the neural tube of fetuses. In humans, folate deficiency is present in approximately two thirds of
chronic alcoholics which is in part due to folate deficiency in the diet, but also due to decreased
absorption of folate in response to ethanol (Bode and Bode 2003). One-hour treatment of a
binge-like dose of ethanol (65 mmol/L) decreased apical folate absorption in renal human
proximal tubule cells by 20-25%. This ethanol-mediated decrease in folate absorption was not
seen at the BLM.
Furthermore, increased expression of the reduced folate carrier and folate receptor
occurred in response to 14 days of 5% w/v ethanol exposure in the nephrons of rats. This study
used a dose of ethanol researchers deemed ‘sub-chronic,’ less than 65 mmol/L, in which
researchers determined that the longer exposure to lower levels of ethanol increased the
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expression of the folate carrier and folate receptor, but acute doses led to inhibitory effects on
folate transport (Romanoff, Ross et al. 2007). However, a 20% dose of ethanol showed no
change in folate transport in jejunal everted sacs in rats (Racusen and Krawitt 1977).
Additionally, a previously discussed study using a heavy 21-day dose of 12% v/v red wine or
ethanol in male Wistar rats found no change in folate transport in the jejunum as well (Lemos,
Azevedo et al. 2005). Therefore, changes to folate absorption were seen in the kidney at the level
of the folate carrier and receptor in response to ethanol (Romanoff, Ross et al. 2007), but some
studies did not see changes in intestinal absorption of folate in response to ethanol (Racusen and
Krawitt 1977, Lemos, Azevedo et al. 2005).
Other studies conducted more specifically at the BBM of the small intestine have shown
malabsorption of folate upon exposure to ethanol (Hamid, Wani et al. 2007, Thakur, Rahat et al.
2015). Researchers found that male Wistar rats fed a moderate 1 g/kg dose of ethanol for three
months showed decreased 3H-folate transport at the intestinal BBM. Kinetic studies presented
decreased Vmax and increased Km values, suggesting both the number of folate transporters and the
affinity of the folate transporters were decreased in response to ethanol. This decrease in folate
absorption in response to ethanol was shown throughout the crypt-villus axis. At the level of the
folate carrier, protein and mRNA expression levels were decreased in the jejunal tissue along the
entire crypt-villus axis as well. Overall, researchers determined that this decrease in folate
absorption was not due to a change in the architecture of the intestine, as this phenomenon was
observed throughout the crypt-villus axis, but because a change in localization of the folate
carrier from the BBM occurred (Hamid, Wani et al. 2007).
Furthermore, this effect was shown to be reversible in rats treated with a heavy dose of
ethanol as above for three months, and then given a two-month reprieve (Thakur, Rahat et al.
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2015). In this additional study, it was suggested that reduced binding of the SP1 transcription
factor in the promotor regions of the folate carrier may be the cause of the decrease in folate
carrier in response to ethanol (Thakur, Rahat et al. 2015).
Overall, it is important to note that in the past, experiments conducted with certain
procedures may not have found changes in the absorption of certain nutrients based on dosage,
type of ethanol (beer, wine, or liquor), and even the experimental techniques used. These
variables may explain why decreased absorption of folate was not found in past studies (Racusen
and Krawitt 1977, Lemos, Azevedo et al. 2005). Nevertheless, ethanol clearly has an effect on
folate absorption in the kidney and small intestine at the level of the folate transporter (Bode and
Bode 2003, Hamid, Wani et al. 2007, Romanoff, Ross et al. 2007, Thakur, Rahat et al. 2015).
Riboflavin (vitamin B2)
Riboflavin absorption was inhibited in male Wistar rats fed the Lieber DeCarli diet for
four weeks at the BBM and BLM of the small intestine (Subramanian, Subramanya et al. 2013).
Decreased riboflavin transporter protein expression and hnRNA levels, which measures rate of
transcription, were present. Ethanol-mediated riboflavin malabsorption was also demonstrated in
the colon and the kidney. In the kidney, renal BBM and BLM absorption was reduced as well as
the protein, mRNA, and hnRNA expression levels of the riboflavin transporter. Overall, this
study presents another case in which ethanol mediates a decrease in the nutrient absorption along
the small intestine, as well as in other organs (Subramanian, Subramanya et al. 2013).
Vitamin C
In chronic alcoholics, low blood levels of ascorbic acid, a fraction of vitamin C, are often
present (Bode and Bode 2003). In addition to excess excretion and dietary insufficiencies present
in alcohol-dependent malnutrition, ethanol has been shown to affect the vitamin C co-
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transporters directly. In Kunming mice fed a heavy dose of 25% ethanol diet for two weeks,
ethanol increased the expression of two sodium-dependent vitamin C co-transporters in the
kidney and the intestine (Guo, Wang et al. 2013). The increased expression of these vitamin C
co-transporters was reversed with the addition of 1.5 mM or 3 mM vitamin C supplementation,
which suggests that vitamin C can regulate itself, by suppressing hypoxia-inducible factor-α
(Guo, Wang et al. 2013). This study stands out, as it provides evidence that ethanol does not
suppress expression of all nutrient transporters.
Other vitamins
Vitamins A, D, E, and K are mildly deficient in chronic alcoholics, which varies by the
individual (Bode and Bode 2003). The exact mechanism of the malabsorption of these other
vitamins is yet to be explored. Moreover, vitamin B6 (pyridoxal-5-phosphate) deficiency is
frequently observed in chronic alcoholics (Bode and Bode 2003) which is in part due to ethanoldependent inhibition of intestinal hydrolysis of the vitamin (Middleton 1986).
Ethanol’s effect on mineral absorption
Calcium
Net calcium absorption was decreased following an intragastric gavage of moderate
ethanol (2 g/kg) in fasted rats (Krishnamra and Limlomwongse 1987). Ethanol stimulated
calcium secretion in the stomach and the distal small intestine, while inhibiting absorption along
the proximal small intestine. Furthermore, the addition of heavy dose of 7% ethanol, but not
3.5% ethanol, in canine jejunal Thirty-Vella loops increased the secretion of calcium. Serum
calcium levels were unaffected (Money, Petroianu et al. 1990). An acute 3 g/kg intragastric
gavage of ethanol also led to net calcium secretion after 30 minutes in rats (Krishnamra and
Limlomwongse 1987). Overall, ethanol stimulates calcium secretion and decreases calcium
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absorption. However, it is debated on how much ethanol affects net calcium absorption and
secretion in the entire small intestine.
Zinc
Zinc deficiency is associated with chronic alcohol use (Bode and Bode 2003). Male
Sprague-Dawley rats fed a Lieber DeCarli ethanol diet for one month displayed decreased zinc
absorption (16%) in the ileum using in vivo perfusion (Antonson and Vanderhoof 1983).
Furthermore, male Sprague Dawley rats fed a Lieber DeCarli diet for six weeks showed that the
zinc transporter mRNA expression levels were significantly decreased at both the apical and
BLM of the duodenum (Joshi, Mehta et al. 2009). Zinc absorption also plays a significant role in
ethanol-mediated TJ disruption discussed later.
Iron
Higher concentrations of iron are common in chronic alcoholics. In six male chronic
alcoholics, intestinal iron absorption was increased two-fold (Duane, Raja et al. 1992).
Michaelis-Menten kinetic experiments in tissues from control subjects and chronic alcoholics
showed a linear relationship with exposure to increasing iron concentrations. Further
experiments showed an increase in intestinal permeability as well, and it was hypothesized that
this increase in iron absorption in chronic alcoholics is due to an increased paracellular route of
passive absorption of iron in chronic alcoholics (Duane, Raja et al. 1992). In another study, a
heavy dose of ethanol was administered in the drinking water of male Swiss mice (200 mL/L)
over 13 weeks (Sabino, Petroianu et al. 2010). It was determined that iron absorption in the
duodenum was not altered. Therefore, ethanol increases the paracellular passive absorption of
iron in the lower small intestine alone (Sabino, Petroianu et al. 2010).
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Magnesium
Hypomagnesaemia is common in chronic alcoholics, but it is due to excess excretion
rather than due to malabsorption of magnesium (Bode and Bode 2003).
Selenium
Diminished selenium is present in the serum of chronic alcoholics (Bode and Bode 2003).
However, duodenal absorption of selenomethionine increased in Wistar rat offspring through an
increase in the affinity of the transporter (Km) following a heavy dose of 20% v/v ethanol dose
during the four weeks of gestation and lactation (Nogales, Ojeda et al. 2011). This study
describes a selective case in which the absorption of a nutrient increased in response to ethanol.
The differences in selenium presence, between those reported in the serum of chronic alcoholics
and this study, may be due to the age of the rats used in this study (Nogales, Ojeda et al. 2011).
Summation of ethanol’s effect on nutrient absorption
The effect of ethanol on nutrient absorption has been well-detailed by a vast amount of
literature spanning the mid-20th century. Ethanol decreases the absorption of a wide variety of
nutrients including vitamins and glucose (Table 3). This malabsorption stems from dietary
deficiencies in chronic alcoholics, but at the cellular level, is also due to changes to nutrient
absorption by nutrient transporters. Throughout the research, this phenomenon spans many
species and tissues, but each nutrient is differentially affected by ethanol. Further research is
required to tease out the action of ethanol on each affected nutrient. In fact, ethanol may affect
other nutrients not yet investigated (Bode and Bode 2003). One nutrient that has not yet been
examined under ethanol exposure is the conditionally essential amino acid glutamine, which will
be discussed in the following chapters.
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Table 3: Ethanol’s effect on intestinal nutrient absorption. * - n/c only refers to Lemos,
Azevedo et al. 2005, ** - n/c only present in upper jejunum, n/c – no change, ↓ - decrease, ↑ increase, BAC – blood alcohol content.
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ETHANOL METABOLISM
Ethanol clearly affects nutrient absorption along the small intestine. However, how
ethanol affects each nutrient is not clear. There must be mechanisms of action of ethanol on
intestinal cells, in order to have such a pervasive effect on nutrient absorption. To better explore
potential mechanisms that describe how ethanol affects nutrient absorption, the effect of ethanol
in cells must be fully examined, starting with the metabolism of ethanol.
Ethanol metabolism via ADH
Ethanol, as previously mentioned, is oxidized to acetaldehyde through ADH. This
enzymatic reaction is reversible. Acetaldehyde is toxic at extremely low concentrations, forming
adducts at concentrations as low as 5 µM; therefore, the body quickly oxidizes acetaldehyde to
its non-harmful metabolite acetate using aldehyde dehydrogenases (ALDH) primarily in the liver
(Fisher, Swaan et al. 2010). As ethanol is oxidized, nicotinamide adenine dinucleotide (NAD)
accepts the hydrogen atoms removed from ethanol and then acetaldehyde, which changes NAD
to NAD+ to NADH. In cells, this lowers the NAD+/NADH redox ratio which can inhibit
glycolysis, the citric acid cycle, pyruvate dehydrogenase, fatty acid oxidation and
gluconeogenesis. The acetate produced from the metabolism of ethanol is used to form acetyl
coenzyme A, which is an important precursor in all major nutrients like fat, carbohydrates and
protein (Figure 2) (Cederbaum 2012).
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Figure 2: Pathways of ethanol metabolism. Ethanol is mainly metabolized by alcohol
dehydrogenase in the liver creating acetaldehyde. Other pathways of ethanol metabolism exist,
primarily using the CYP2E1 and catalase enzymes. Acetaldehyde is then rapidly metabolized to
acetate through alcohol dehydrogenase. ADH – alcohol dehydrogenase, ALDH – Aldehyde
dehydrogenase, NAD+ - nicotinamide adenine dinucleotide (oxidized), NADH - nicotinamide
adenine dinucleotide (reduced), CYP2E1 – cytochrome P450 2E1.

Alcohol dehydrogenase
Ethanol is primarily metabolized through the enzyme ADH. ADH has five isoenzymes in
many tissues including in the cytosolic fractions of liver, intestinal (Julia, Farres et al. 1987,
Bode and Bode 2003, Fisher, Swaan et al. 2010), kidney, testicular and uterine cells. In the
intestine, ADH2 is the predominate isoform (Julia, Farres et al. 1987). ADH broadly oxidizes
primary and secondary alcohols. Although this one type of enzyme is the predominant machinery
responsible for ethanol metabolism, this enzymatic reaction is not a zero-order process;
therefore, ethanol is not metabolized at a constant rate. The kinetic ability of ADH isoenzymes is
approximately 1 mM, which is low and slow. Therefore, at higher concentrations of ethanol,
ADH becomes easily saturated. As a compensatory mechanism, alternate pathways of ethanol
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metabolism become more active: including cytochrome P450 2E1 (CYP2E1) discussed below
(Cederbaum 2012).
Alternate pathways of ethanol metabolism
The metabolism of ethanol can occur through several different pathways: primarily
through ADH, and to a lesser extent through peroxisomes and the cytochrome P450-dependent
ethanol-oxidizing system. Ethanol can also interact with fatty acid ethyl esters as a form of
metabolism as well (Cederbaum 2012).
Peroxisomes
Ethanol oxidation in peroxisomes occurs through an enzyme called catalase. Catalase can
oxidize ethanol to acetaldehyde using peroxide but has a slower metabolism rate of ethanol due
to the lower levels of peroxide in cells (Cederbaum 2012).
CYP2E1
Ethanol is also metabolized through the microsomal cytochrome P450 enzyme, mainly in
the liver. P450s are found in the mitochondria and endoplasmic reticulum. There are many
isoforms of P450s; moreover, CYP2E1 is a type of P450 enzyme which metabolizes ethanol. The
Km of CYP2E1 is 10 mM, which is higher than the Km for ADH. However, at low concentrations
of ethanol, CYP2E1 may only account for 10% of total ethanol metabolism. On the other hand,
at higher concentrations, the CYP2E1 plays a greater role in ethanol metabolism and expresses
increased function during chronic ethanol administration. CYP2E1 degrades ethanol at higher
rates than ADH, which surprisingly leads to an even higher overall metabolism rate of ethanol at
higher ethanol concentrations which plays a role in ethanol tolerance (Cederbaum 2012).
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Acetaldehyde metabolism
Aldehyde dehydrogenase
ALDH oxidizes acetaldehyde to acetate rapidly. ALDH is present in the mitochondrial,
microsomal and cytosolic compartments which have various isoforms of ALDH with differing
Km values. Overall, ALDH is highly present in the liver, and the enzyme is rarely saturated. This
enzyme is very efficient because accumulation of acetaldehyde can lead to nausea, vomiting,
increased heart rate and other negative symptoms (Cederbaum 2012). Therefore, it is important
to fully express this enzyme involved in ethanol metabolism. However, ALDH expression can
vary by race, with a significant amount of people of East Asian descent having an inactive form
of ALDH2 leading to higher concentrations of acetaldehyde in the blood. This phenotype leads
to increased vasodilation and nausea when consuming alcohol in these individuals (Cederbaum
2012). This inactive form of ALDH2 also increases cancer risk along the GI tract in these
individuals (Seitz and Stickel 2010).
Consequences of acetaldehyde
Concentration of acetaldehyde in the gastrointestinal tract
Acetaldehyde studies often take place in the colon, rather than in the small intestine, since
acetaldehyde concentrations in the colon often exceed concentrations present in the small
intestine which is due to the low rate of acetaldehyde metabolism in the colon coupled with the
presence of colonic bacteria that also produce acetaldehyde from endogenous and ingested
alcohols (Basuroy, Sheth et al. 2005). Researchers have determined that the concentration of
acetaldehyde can reach 0.5 to 3 mM in the colon following a dose of 1.5 g/kg ethanol in rats
which is an impressive concentration as much smaller concentrations of acetaldehyde (99-760
µM) can lead to increased permeability in Caco-2 cells, a colon cancer-derived cell line
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(Atkinson and Rao 2001). In the intestine, concentrations of acetaldehyde can reach upwards of
100 µM (Jokelainen, Matysiak-Budnik et al. 1996, Koivisto, Kaihovaara et al. 1999, Ferrier,
Berard et al. 2006).
Acetaldehyde adducts
When acetaldehyde is not rapidly metabolized, this molecule can cause havoc around the
cell. Acetaldehyde, at extremely low concentrations, can react with thiols and amino groups to
form acetaldehyde adducts that directly cause cellular toxicity (Cederbaum 2012). Acetaldehyde
can bind to DNA and form carcinogenic adducts and create genetic polymorphisms (Seitz and
Stickel 2010). These adducts can form at concentrations as low as 5 µM of acetaldehyde. Lysine
is the most common adduct formed with acetaldehyde, which is called a Schiff’s base (Fisher,
Swaan et al. 2010). Acetaldehyde can also increase tumorigenesis. In a study using ALDH1B1
knock down mice, a heavy dose of ethanol (20% v/v) for one year led to high concentrations of
plasma acetaldehyde (1.5 µg/mL) (Muller, Zhou et al. 2017). All ethanol-exposed mice had
intestinal hyperproliferation and advanced intestinal tumors with no increase in tumor incidence
which suggests that excess acetaldehyde increases the proliferation of tumors in these mice.
Overall, acetaldehyde must be rapidly metabolized in cells to avoid causing cellular damage and
even tumorigenesis (Muller, Zhou et al. 2017).
Acetaldehyde’s action on TJs
One of acetaldehyde’s major actions on the intestine occurs through impairing the
intestinal epithelial barrier by increasing TJ permeability (Bode and Bode 2003, Fisher, Swaan et
al. 2010). In Caco-2 cells treated with a heavy dose of ethanol (20% v/v), leading to
acetaldehyde concentrations of approximately 1 mM, permeability of low weight molecular
markers, mannitol and sucrose, were increased. The same phenomenon was able to be shown
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with rats treated with heavy dose of ethanol (5 g/kg) for six days. However, acetaldehyde had no
change in permeability of the high weight molecular marker inulin in these experiments (Fisher,
Swaan et al. 2010).
In another study investigating acetaldehyde’s effect on TJ permeability in Caco-2 cells,
researchers determined that genistein (30-300 µM) was able to reverse the decreased
permeability in TJs in response to 650 µM acetaldehyde. Researchers also began to illustrate a
mechanism of how acetaldehyde interacts with the intestinal epithelium. Researchers showed
that there was increased phosphorylation of vital tight (occludin and ZO-1) and adheren’s (Ecadherin) junction proteins. In addition, researchers discovered that this dose of acetaldehyde in
Caco-2 cells decreased protein tyrosine phosphatase (PTPase) activity (Atkinson and Rao 2001).
The same group of researchers also showed that acetaldehyde (100-600 µM) increased protein
tyrosine phosphatase phosphorylation of occludin, E-cadherin, ZO-1 and β-catenin in human
colon samples. Therefore, acetaldehyde caused the redistribution of TJ and adheren’s junction
proteins, increasing intestinal epithelium permeability, due to PTPase and tyrosine phosphatase
modulation (Basuroy, Sheth et al. 2005).
Excess acetaldehyde may have serious consequences in the intestine. For example, it can
alter the permeability of the mucosa and thus promote the translocation of bacteria. Indeed,
endotoxemia, known to be present following acute ethanol use in humans may be important in
the causation of cirrhosis (Bode, Kugler et al. 1987). Therefore, an important component in the
metabolism of ethanol includes the alteration of TJs caused by the primary toxic metabolite of
ethanol metabolism, acetaldehyde (Ferrier, Berard et al. 2006).
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Variations in ethanol metabolism rate
There is a high variability of ethanol metabolism between individuals due to the
previously mentioned physiological variables as well as by the dose of ethanol, food intake, body
weight, drinking pattern, age, and sex (Stockwell and Room 2012). Men and women achieve
different BAC when exposed to the same dose of alcohol per unit of body weight which is in part
due to the higher body fat percentage in women, leading to higher BAC in women. There is also
higher first pass metabolism in men as well (Cederbaum 2012). Ethanol metabolism also varies
based on previous alcohol use in each individual. Overall, ethanol is generally metabolized at
approximately one standard drink per hour (Cederbaum 2012).
THE EFFECT OF ETHANOL ON INTESTINAL STRUCTURE AND FUNCTION
Common intestinal complications of chronic alcoholics include malnutrition and diarrhea.
The malnutrition stems from dietary insufficiencies in addition to decreased nutrient absorption
as discussed above. The diarrhea often stems from increased permeability of the TJs seen during
chronic alcohol consumption which leads to the passive diffusion of solutes like sodium and
chloride back into the lumen, causing water to follow (Ferrier, Berard et al. 2006). This diffusion
of solutes, coupled with decreased activity of mucosal disaccharidases, causes the diarrhea. The
following section describes the effect of ethanol on intestinal structure and function, as these
changes can lead to larger symptoms as with diarrhea (Bujanda 2000).
Effect of ethanol on intestinal function
Ingested food must pass through the GI tract which requires the muscular, endocrine, and
enteric systems to produce contractions in the intestine to move the ingested material through the
GI tract. Chronic alcohol consumption alters bowel motility, which could stem from ethanolbased alterations to contractile proteins, vagal function, or impairment of neuroendocrine factors
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(Bujanda 2000). These results are also ileal-specific. Researchers showed that a 3 to 5% dosage
of ethanol in the ileum can decrease slow wave activity, which inhibited intestinal contractions in
a dose-dependent manner (Subramanya, Stephen et al. 2015).
Effect of ethanol on the intestinal microbiota
Since ethanol affects the motility of the GI tract, ethanol may also affect the composition
of the intestinal microbiota. It has been shown that ethanol creates bacterial overgrowth in the
small intestine (Hauge, Persson et al. 1997). In human subjects, almost half of chronic alcoholics
had an increase in the total number of bacteria in the jejunum and duodenum of the small
intestine (Hauge, Persson et al. 1997). More specific microbiota compositional changes have also
been recorded. The intestinal microbiota in mice exposed to 30.9 g/kg of ethanol were
investigated by 16S rRNA from cecum fecal samples. Overall, they found that ethanol increased
Bacteroidetes and decreased Firmicutes presence (Yan, Fouts et al. 2011). A similar human
study using mucosa sigmoid biopsies from chronic alcoholics showed an increase in
Proteobacteria and a decrease in Bacteriodetes, which differed from the previous mouse study,
using 16S rRNA (Mutlu, Gillevet et al. 2012). A similar human study conducted with fecal
samples found the same compositional changes in the microbiota (Chen, Yang et al. 2011).
Researchers even compared the composition of the microbiota when exposed to red wine
consumption to gin and de-alcoholized red wine in humans (Queipo-Ortuno, Boto-Ordonez et al.
2012). Researchers found that each of these beverages changed the composition of the
microbiota differently. In all, alcohol clearly causes bacterial overgrowth and compositional
changes in the microbiota, which depends on many factors, even on the type of alcohol
consumed (Engen, Green et al. 2015). Bacterial overgrowth and microbiota changes may
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contribute to increased endotoxin translocation, causing liver damage, or even damage the
mucosa, contributing to alcohol-dependent malnutrition (Bode and Bode 2003).
Effect of ethanol on intestinal structure
Acute doses of ethanol can damage the mucosa through a loss of epithelial cells at villus
tips, reduced villus height, reduced mucosal surface area per villi, increased intra-epithelial
mononuclear cells, goblet cell hyperplasia, presence of hemorrhagic erosions and hemorrhage in
the lamina propria (Beck and Dinda 1981). Moreover, fluid-filled blebs at the tips of villi form
when exposed to 2.1 – 4.8% ethanol in the perfused hamster jejunum as well as in human tissues
which was reversible within 45 minutes (Beck and Dinda 1981). In some studies, the blebs had
ruptured (Beck and Dinda 1981).
In further studies, chronic alcohol use in 120 male alcoholics consuming more than 80 g
of ethanol per day were monitored for three months. Duodenal biopsies showed partial villus
atrophy, lamina propria infiltrate, intraepithelial lymphocytes with wide intracellular junctions,
distorted microvilli, increased endoplasmic reticulum and increased and dilated mitochondria
(Bhonchal, Nain et al. 2008).
Overall, there is vast and varied structural damage in response to ethanol along the small
intestine. Although some studies illustrated the damage occurs in a dose-dependent manner, the
level and types of damage varied heavily between species, ethanol dosage, and intestinal
segment examined. Furthermore, the exact mechanism of these changes is still well debated
(Bode and Bode 2003).
Effect of ethanol on cellular structure
In addition to the function and structural changes in the intestine, ethanol has distinct
subcellular effects as well. Perfusion of a binge-like dose of ethanol (2.1 – 4.8%) in the hamster
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jejunum resulted in the swelling of the cells located at the villus tips (Beck and Dinda 1981). The
swelling could be reversed in 45 minutes and the mechanism remains unclear (Beck and Dinda
1981). Electron microscopy also showed wide intracellular junctions, increased and dilated
mitochondria, distorted microvilli, and increased mature epithelium at villus tips in duodenal
biopsies from male chronic alcoholics (Bhonchal, Nain et al. 2008). Overall, there are also
subcellular changes in response to ethanol, including those discussed below.
The effect of ethanol on subcellular structures
The effect of ethanol on membrane fluidity
Ethanol is amphiphilic which means that ethanol can passively diffuse through cell
membranes. When this small short-chained alcohol inserts itself into the plasma membrane of
cells, the hydrophobic portion of ethanol interacts with the lipid hydrocarbon chains of the
plasma membrane. Meanwhile, the polar hydroxyl group of ethanol forms hydrogen bonds with
the polar lipid atoms of the plasma membrane. This insertion creates a reaction across the plasma
membrane, changing the fluidity of the membrane (Dickey and Faller 2007). This insertion can
occur in 400 nanoseconds (Patra, Salonen et al. 2006). Researchers showed that ethanol increases
membrane fluidity and decreases bilayer thickness as it traverses the membrane in computer
simulations (Patra, Salonen et al. 2006, Dickey and Faller 2007). This result was shown again in
Oenoccus oeni cells (Da Silveira, Golovina et al. 2003). Any changes in membrane fluidity, such
as changing bilayer thickness, can alter the conformation of transporters in the plasma membrane
(Dickey and Faller 2007). Changes in membrane fluidity can even play a role in altering Na-KATPase activity (Da Silveira, Golovina et al. 2003). Therefore, it is important to fully understand
ethanol’s effect on the plasma membrane of cells.
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Ethanol also causes the membranes to become more disordered. Ethanol increases the
rotation of phospholipids and the wobbling of acyl chains of phospholipids. It has been
hypothesized that although significant membrane alteration occurs at 10 to 20 mM of moderate
ethanol exposure, the amount of disorder caused is similar to that of a one-degree temperature
change. Nevertheless, it has been suggested that the membrane order can adapt to continuous
exposure to drugs like ethanol. Mice resistant to intoxication have less of an effect on membrane
disorder than ethanol-sensitive mice (Goldstein 1987). Overall, more research is clearly needed
to fully understand the effect of ethanol on the plasma membrane and its involvement with
ethanol tolerance.
Effect of ethanol on TJs
Ethanol has been shown to modify TJ proteins. TJ proteins are imperative in maintaining
the intestinal epithelium as a selective barrier to the lumen. TJ manipulation leads to a leaky
intestinal lining, endotoxin translocation, and then liver damage commonly associated with
chronic alcohol use (Ferrier, Berard et al. 2006). Intestinal epithelial permeability in response to
ethanol is commonly decreased. For example, in the colon, increased intestinal permeability was
seen in concentrations of ethanol above 5%, leading to a 10% decrease in colonic transepithelial
resistance (Ferrier, Berard et al. 2006). Sprague Dawley rats treated with 3 g/kg ethanol, leading
to BAC levels of approximately 0.08% two hours after the treatment, showed increased 51CrEDTA permeability, but not in doses less than 3 g/kg. Furthermore, use of antibiotics and mast
cell stabilizers lessened the effect of ethanol on the permeability of the epithelial cells (Ferrier,
Berard et al. 2006). Even though these studies were conducted in the colon, similar studies found
ileal permeability is also similarly affected by acetaldehyde as previously discussed above
(Chaudhry, Samak et al. 2015).
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This increase in intestinal permeability may be due to TJ stability. Ethanol at
concentrations less than 10% caused myosin light chain kinase upregulation and actin
modulation by removing ZO-1 and occludin from the TJs in Caco-2 cells and the duodenal tissue
of healthy humans (Elamin, Masclee et al. 2014). This process was reversible with the removal
of ethanol (Elamin, Masclee et al. 2014).
Further studies conducted by the same group showed that in Caco-2 cells, a binge-like
dose of ethanol exposure (40 mM) for five minutes caused a calcium-dependent activation of the
Rho/ROCK pathway which leads to intestinal barrier disruption through JNK2 (Elamin, Masclee
et al. 2014). The influx of calcium through L-type voltage-gated calcium channels led to the
redistribution of occludin-1, E-cadherin, β-catenin and F-actin from the tight and adheren’s
junctions which was reversed with the Rho/ROCK inhibitor Y-27632 (Elamin, Masclee et al.
2014). Furthermore, butyrate supplementation (10 mM tributyrin) after gut injury in mice
(C57BL/6J) treated with a chronic 32% ethanol-diet for 25 days showed no change in the
presence of ZO-1 and occludin in the TJ (Cresci, Bush et al. 2014). The supplementation of
tributyrin protected these proteins from the effect of ethanol. Overall, ethanol affects TJ proteins,
which can contribute to a leaky intestinal barrier and nutrient malabsorption, in a variety of ways
that can be reversed using Rho/ROCK inhibitors or tributyrin supplementation.
Zinc and TJ regulation
Zinc seems to play a role in the ethanol-mediated intestinal barrier disruption. Mice
(C57BL/6J) were fed a Lieber DeCarli ethanol diet for four weeks and showed reduced ileal zinc
concentration and increased reactive oxygen species (ROS) in the ileum, but not the jejunum or
duodenum (Zhong, McClain et al. 2010). Ethanol also decreased ZO-1, occludin and claudin-1
expression in TJs. Researchers suggested that this zinc deficiency may play a role in this TJ
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disassembly. More importantly, this research showed that the ileum, not the upper small
intestine, plays a greater role in endotoxemia development (Zhong, McClain et al. 2010). Further
studies by the same group showed that chronic ethanol, administered in the same way, reduced
hepatocyte nuclear factor-4α (HNF-4α) expression, mostly in the ileum (Zhong, McClain et al.
2010). When HNF-4α was knocked down in Caco-2 cells, TJ mRNA and protein expression
levels decreased, and intestinal permeability increased, as measured by transepithelial resistance.
This study suggests that decreased nutrient absorption of zinc in response to ethanol reduced
HNF-4α expression and then leads to TJ dysregulation and intestinal permeability (Zhong, Zhao
et al. 2010). Furthermore, supplementation of zinc in an alveolar epithelial monolayer from
Sprague Dawley rats fed a Lieber DeCarli diet for six weeks displayed increased epithelial
barrier function, TJ protein expression and localization (Joshi, Mehta et al. 2009). Altogether,
these reports show that decreased TJ protein expression following ethanol exposure can be
reversed with correct nutritional absorption of zinc.
Effect of ethanol on cellular stress and immune responses
Since ethanol creates cellular and structural damage along the small intestine, it is
reasonable to assume that an immune response is initiated in response to ethanol. In fact,
leukocyte infiltration is present in jejunal segments perfused with a binge-like dose of 6%
ethanol (Dinda, Kossev et al. 1996). As a secondary cascade, histamine is released from mast
cells. This process quickly reverses itself within days of abstinence in chronic alcoholics.
Reversal of increased B-lymphocytes and mononuclear macrophages in the lamina propria was
also present within 5-10 days of abstinence in human chronic alcoholics (Bode and Bode 2003).
Ethanol has been shown to induce stress-related proteins as well as modulating the
immune response. The increased expression of heat shock protein (HSP) 70 was shown in a
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dose-dependent manner in mice given a 2.75, 5.5, and 8.25 g/kg ethanol for one hour (Lee, Choi
et al. 2014). HSP40, HSP32, and HSP90 levels were also altered, but the changes depended on
the intestinal segment and ethanol concentration. In the same study, interleukin-1β, tumor
necrosis factor-α (TNF-α), and cyclooxygenase-2 (COX-2) were all increased in response to all
the ethanol doses. In all, ethanol is causing stress and immune responses to occur in intestinal
epithelial cells, due to the presence of stress-related HSPs and immune system modulators like
TNF-α (Lee, Choi et al. 2014).
These studies are only a small picture of the immune and stress responses engaged by
ethanol. There are a large amount of ethanol studies detailing the different immune and stress
responses (Bode and Bode 2003). It is important to consider these responses in future ethanol
studies.
Ethanol and reactive oxygen species (ROS) production
ROS are produced from ethanol metabolism. One pathway for ROS generation is during
the production of hydrogen peroxide, in which oxygen can react with iron or copper ions to form
hydroxyl radicals. Ethanol also alters complex I and complex III of mitochondria, which can lead
to ROS production (Ishii, Kurose et al. 1997). Alterations in NAD+/NADH ratio may exaggerate
mitochondrial superoxide generation by increasing electron flow along the electron transport
chain (Ishii, Kurose et al. 1997). ROS can damage many cellular functions and structures,
including those at the cell membrane. Since ethanol has already been shown to alter TJ
permeability, the production of ROS in response to ethanol should be noted.
Ethanol increased lipid peroxidation and reduced the antioxidant enzyme glutathione
peroxidase in male Marchigian Sardinian alcohol-preferring rats administered 10% ethanol for
10 weeks (Gabbianelli, Cifani et al. 2007). No change in superoxide dismutase was recorded
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(Gabbianelli, Cifani et al. 2007). In another study, rabbits were given a heavy dose of 5 g/kg
ethanol for six weeks and lipid peroxidation production was measured with TBARS (RasicMarkovic, Krstic et al. 2008). Lipid peroxidation increased in the ethanol-treated rabbit
erythrocytes (Rasic-Markovic, Krstic et al. 2008). Focusing in on the GI tract, in Caco-2 cells
exposed to 0-15% ethanol, an increase in oxidative stress and inducible nitric oxide synthase
(iNOS) occurred as well (Banan, Choudhary et al. 1999). Similarly, researchers found an
increase in iNOS activity in the ileum and colon in rats administered a heavy dose of 20%
ethanol for eight weeks (Krecsmarik, Izbeki et al. 2006). A decrease in constitutive nitric oxide
synthase (cNOS) was also present which is important because nitric oxide inhibits the enteric
nervous system which can lead to the motility disorders associated with chronic alcohol use
(Krecsmarik, Izbeki et al. 2006).
CONCLUSION
Alcohol is commonly used by the majority of the population of the United States.
However, it’s use leads to negative health consequences including alcohol-dependent
malnutrition. Ethanol does decrease the absorption of many nutrients including thiamine, folate,
riboflavin, vitamin C, glucose and more in the small intestine. However, the mechanism of action
of ethanol on decreased nutrient transport is unclear which may be in part due to the primary
toxic metabolite of ethanol, acetaldehyde, or due to the changes the small intestine experiences in
response to ethanol including changes to the structure and function of the small intestine,
changes to the microbiota composition, increases in ROS generation and alterations to plasma
membrane fluidity, TJs, and epithelial permeability. Clearly, alcohol consumption leads to
complicated, direct and indirect actions on many bodily processes (Figure 3). More research is
necessary to fully understand ethanol’s effect on nutrient absorption at the small intestine.

41

Figure 3: The effects of alcohol consumption along the small intestine. Alcohol consumption
can lead to a wide variety of negative cellular responses including intestinal inflammation,
decreased nutrient absorption, increased acetaldehyde production and alterations in intestinal
structure and function. ROS – reactive oxygen species, HSP – heat shock protein, GI –
gastrointestinal tract.
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CHAPTER 2
GLUTAMINE AND GLUCOSE ABSORPTION ALONG THE SMALL INTESTINE
Glutamine
Glutamine is a conditionally essential amino acid, meaning that glutamine can be
synthesized adequately by the body, but in certain tissues is required for optimal health,
especially in the intestine (Lacey and Wilmore 1990). However, this definition does not provide
adequate emphasis to express glutamine’s importance in the mammalian body. Glutamine helps
maintain normal function of the intestine, kidney, liver, heart, brain, pancreas, and immune
system. Glutamine is involved in insulin secretion, cytokine production, apoptosis, redox
potential, cell stress responses, protein degradation and synthesis, extracellular matrix formation,
cellular proliferation, and cellular metabolism. Furthermore, glutamine is used as a substrate and
regulator in gluconeogenesis, the TCA cycle, the urea cycle, and lipogenesis. Glutamine is also a
precursor for nucleotides. Clearly, this amino acid has wide ranging roles across the mammalian
body (Curi, Lagranha et al. 2005).
Glutamine’s role along the intestine
In addition to being involved in many important bodily functions, glutamine is the
primary fuel source for the small intestine. The intestinal epithelium must constantly renew
itself, and these rapidly dividing cells use glutamine as a reliable source of energy production.
Overall, approximately 70% of consumed glutamine is absorbed and catabolized by enterocytes
(Pochini, Scalise et al. 2014). In addition to its roles in intestinal cell proliferation, glutamine
also protects the intestinal epithelium from ROS. Glutamine is a precursor for the antioxidant
glutathione, which helps prevent ROS damage. Glutamine also activates signaling mediators that
regulate cellular differentiation and mucin production, which protects the integrity of the

43

intestinal epithelium (Kim 2011). Glutamine can induce the expression of the cellular stress
response proteins like HSPs and decreases the immune response, through decreasing toll-like
receptor 4 induction (Kim 2011). These processes help regulate the stress and immune responses
in the intestinal barrier. Due to this wide range of protective functions in the intestine, glutamine
is an important nutrient to fully investigate (Kim 2011).
B0AT1
Glutamine is absorbed along the small intestine through the sodium-dependent glutamine
co-transporter B0AT1. B0AT1 (SLC6A19) belongs to the B0 family, which has a broad
specificity to neutral amino acids. Several other transporter families are also selective for
glutamine, including the SLC1, 6, 7, and 38 (Pochini, Scalise et al. 2014). B0AT1 also transports
leucine, valine, methionine, phenylalanine, tryptophan, threonine and histidine (Broer 2009).
B0AT1 is an electrogenic co-transporter that is pH-sensitive. B0AT1 transports sodium
and glutamine at a 1:1 ratio but cannot transport lithium. This co-transporter functions based on
sodium. Sodium travels along its concentration gradient into the cell while glutamine is
transported against its concentration gradient into the cell through B0AT1. This sodium gradient
is set by the Na-K-ATPase on the BLM of enterocytes. Therefore, B0AT1 functions from
secondary active transport (Pochini, Scalise et al. 2014).
B0AT1 has 12 transmembrane domains. Uncharged amino acids are favored in the
hydrophobic pocket of B0AT1 formed by a hypothesized leuT fold. There are five predicted Nglycosylation sites, an intracellular phosphorylation site and two possible metal binding motifs in
the middle of the co-transporter (Pochini, Scalise et al. 2014). Nimesulide and benztropine are
two competitive inhibitors of B0AT1 (Cheng, Shah et al. 2017).
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B0AT1 localization
B0AT1 is localized in the proximal tubules, kidney, skin, pancreas, prostate, stomach,
liver and the BBM of intestinal microvilli. Specifically in the small intestine, this co-transporter
was localized via immunohistochemistry to the villus cells but not to the secretory crypt cells of
the rabbit small intestine (Talukder, Kekuda et al. 2008).
B0AT1 and disease
Mutations in B0AT1 lead to an autosomal recessive disorder called Hartnup disorder.
Occurring more frequently in European populations, Hartnup disorder is often asymptomatic.
However, clinical aspects include renal aminoaciduria presenting with varying symptoms,
including a distinctive skin rash which is caused by the malabsorption of neutral amino acids,
absorbed by co-transporters in the B0 system, in the kidney (Broer 2009).
In the small intestine, B0AT1 has also been shown to be affected through the induction of
chronic intestinal inflammation (Singh, Arthur et al. 2015, Arthur, Singh et al. 2018, Singh,
Arthur et al. 2018). Glutamine absorption was reduced in response to conditions of chronic
intestinal inflammation in rabbits through a reduction in co-transporter number. This alteration
was reversed with the application of glucocorticoids, a broad spectrum immune modulator
(Arthur, Saha et al. 2012) and a mast cell stabilizer ketotifen (Singh, Arthur et al. 2015). The
cyclooxygenase pathway was determined to be the primary regulator of this phenomenon
(Arthur, Singh et al. 2018).
B0AT1 and ethanol
There is no current literature on the effect of ethanol on the sodium-dependent glutamine
co-transporter B0AT1.
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Glucose
Glucose is a monosaccharide and is the primary fuel source for mammalian metabolism.
Glucose travels down the GI tract often as a complex carbohydrate. These complex
carbohydrates are broken down by amylases secreted mainly by the pancreas. These complex
carbohydrates are broken down into monosaccharides like glucose and are then absorbed into
enterocytes (Lehmann and Hornby 2016). Glucose is then often stored as glycogen or travels in
the vascular system to be used as necessary.
Glucose is used as a fuel source in multiple metabolism processes including glycolysis,
the pentose phosphate pathway, the citric acid cycle (Krebs cycle), aerobic respiration and
anaerobic respiration. The breakdown of glucose through these cycles leads to varying amounts
of energy in the form of ATP. Furthermore, glucose can be broken down and built into required
molecules such as lipids, vitamin C and glycogen.
SGLT1
The primary route of glucose absorption is through a sodium-dependent glucose cotransporter located at the BBM of enterocytes called SGLT1 (SLC5A1). SGLT1 is part of the
SLC5 family, which transports sodium with glucose and galactose (Vrhovac, Balen Eror et al.
2015). In fact, SGLT1 was first cloned in 1987 (Hediger, Coady et al. 1987) and was the first
member of the SLC5 family. Transporters in this family also move glucose, fructose, inositol,
short-chain fatty acids, iodide, choline and biotin (Wright, Ghezzi et al. 2017).
Researchers showed that SGLT1 is the primary glucose co-transporter in the small
intestine using BBMVs from wild-type and knock out SGLT1 mice. Compared to wild-type
mice, there was no detectible uptake of the specific glucose co-transporter substrate α-methyl-D-
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glucoside in the knock out mice, showing that SGLT1 is the predominate form of glucose cotransport in the small intestine (Gorboulev, Schurmann et al. 2012).
SGLT1 is composed of 664 amino acids and has 14 transmembrane domains. SGLT1
transports at a 2:1 ratio of sodium to glucose which means that SGLT1 has two sodium binding
sites (Hediger, Coady et al. 1987). When sodium and glucose bind, this closes external gates and
allows the protein to isomerize to move the molecules inward. When the molecules of sodium
and glucose release, the protein reverts externally, which takes in total approximately 20
milliseconds. It is hypothesized that transmembrane domains one, two and ten compose the outer
gates made of hydrophobic side-chains (Wright, Ghezzi et al. 2017).
SGLT1 is considered sodium-dependent, which means that it transports sodium along its
concentration gradient into the cell, which allows the co-transporter to move glucose against its
concentration gradient into the cell. Since SGLT1 is a sodium-dependent co-transporter, it relies
on the BLM-located Na-K-ATPase to maintain the sodium gradient; therefore, this process
occurs through secondary active transport. Furthermore, SGLT1 is coupled with the main Na/H
exchanger 3 (NHE3) in the small intestine (Coon, Kekuda et al. 2008, Lehmann and Hornby
2016).
This electrogenic co-transporter also draws water into the cell. Researchers estimate that
approximately 70% of the passive water flow into the cell is based off the action of SGLT1. It
has been suggested that water co-transports with glucose and sodium, but this point is still
contested today (Wright, Ghezzi et al. 2017).
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SGLT1 inhibition
Due to glucose’s role in type II diabetes and obesity, SGLT1 inhibitors have been well
studied. Phlorizin is one of many SGLT1 inhibitors. Phlorizin binds to the external surface of
SGLT1, only when sodium is bound (Wright, Ghezzi et al. 2017).
SGLT1 localization
SGLT1 is expressed throughout the small intestine, with little to no SGLT1 expression
present in the rest of the GI tract. Lower levels are present in the ileum than the rest of the small
intestine (Lehmann and Hornby 2016). mRNA expression of SGLT1 is present in the intestine,
kidney, brain, spinal cord, spleen, lung, liver, uterus, and pancreas. SGLT1 is expressed in the
human small intestine, liver, lung and heart (Vrhovac, Balen Eror et al. 2015).
SGLT1 and disease
Overall, SGLT1 has a wide applicability in a host of diseases including cholera, type II
diabetes and obesity. During conditions of type 2 diabetes, SGLT1 protein expression levels are
increased (Lehmann and Hornby 2016). SGLT1 may have regulatory roles in conditions of
obesity, as knocking down the SGLT1-regulatory protein RS1 led to an increase in expression of
SGLT1 and corresponding glucose uptake (Lehmann and Hornby 2016). On the other hand,
lacking SGLT1 presents in the rare glucose-galactose malabsorption characterized by severe and
life-threatening diarrhea (Lehmann and Hornby 2016). At the small intestine, recent studies have
demonstrated that chronic intestinal inflammation decreases sodium-dependent glucose cotransport, but not Na/H exchange in rabbit intestinal villus cells which is due to a decrease in the
number of BBM-located SGLT1 co-transporters (Manoharan, Sundaram et al. 2018).
Furthermore, exposure to peroxynitrite also inhibited expression of SGLT1 without changing the
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expression of NHE3, due to a p38 mitogen-activated protein kinase pathway (Manoharan,
Sundaram et al. 2018). Overall, SGLT1 is involved in a variety of different disease states.
The effect of ethanol on SGLT1
The effect of ethanol on glucose absorption was previously detailed in chapter one.
Overall, researchers showed that ethanol decreases glucose absorption in the small intestine.
However, no studies have been conducted directly on SGLT1 using a moderate dose of ethanol.
Ethanol’s effect on the Na-K-ATPase
As absorption of glutamine and glucose along the small intestine are sodium-dependent
processes, it is important to consider the effect of ethanol on the Na-K-ATPase. The Na-KATPase moves three sodium ions out of the cell and two potassium ions into the cell with energy
from ATP. The Na-K-ATPase is located on the BLM of intestinal epithelial cells which
establishes the low concentration of sodium in enterocytes that the sodium-dependent nutrient
co-transporters rely on (Bode and Bode 2003). Therefore, it is important to consider the effect of
ethanol on Na-K-ATPase activity. Studies on Na-K-ATPase activity in response to ethanol have
varied based on the tissue and dosages used. In renal cells, 150 mM ethanol showed decreased
Na-K-ATPase activity in response to acute ethanol and increased activity of the Na-K-ATPase at
chronic doses. A further study by the same group found that chronic ethanol consumption (20%
ethanol for 10 weeks) in renal cells from rats rose due an increase in catalytic units (Rodrigo,
Novoa et al. 1996) and an increase in Vmax parameters which suggests that chronic ethanol
stimulated Na-K-ATPase activity through an increase in the number of catalytic subunits,
specifically the α1 subunit (Rodrigo and Thielemann 1997). The increased activity of the Na-KATPase also varied based on the region of the kidney (Rodrigo, Vergara et al. 1991). In another
study, rabbits given 5 g/kg ethanol for six weeks showed that chronic ethanol consumption
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increased Na-K-ATPase activity in erythrocytes (Rasic-Markovic, Krstic et al. 2008). This
increase in Na-K-ATPase activity in response to chronic alcohol was shown again in rat skeletal
muscle, erythrocytes (Johnson and Crider 1989), lung (Otis, Mitchell et al. 2008), liver (Pascale,
Daino et al. 1989) and in human chronic alcoholics’ erythrocytes (Johnson and Crider 1989).
Researchers hypothesized that this may be due to the changes in membrane fluidity seen in
response to ethanol (Johnson and Crider 1989). The effect of ethanol on the Na-K-ATPase
activity in the intestine was previously described in the jejunum of hamsters, where no chronic
change in Na-K-ATPase activity was determined, but an acute dosage inhibited the activity of
the Na-K-ATPase (Hoyumpa, Patwardhan et al. 1981). In all, there is a wide range of research
describing the effect of ethanol on the Na-K-ATPase in a variety of tissues across the body.
Conclusions
The two main fuel sources for the small intestine and the mammalian body, glutamine
and glucose, are absorbed through sodium-dependent nutrient co-transporters: B0AT1 and
SGLT1, respectively. These transport systems are reliant on the Na-K-ATPase to set the sodium
gradient in intestinal epithelial cells (Figure 4). However, Na-K-ATPase activity is decreased in
response to chronic ethanol in many tissues, but not in the intestine. How ethanol directly affects
B0AT1 and SGLT1 is not known. Further research must be conducted on the effect of ethanol on
B0AT1 and SGLT1 in the small intestine in order to better understand the onset of alcoholdependent malnutrition.
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Figure 4: The sodium-dependent glutamine and glucose co-transporters B0AT1 and
SGLT1, respectively. The sodium-dependent glucose co-transporter SGLT1 moves two sodium
ions into the cell along with one glucose molecule, while B0AT1 draws one sodium ion into the
cell, along its concentration gradient, and one glutamine molecule against its concentration
gradient. The Na-K-ATPase sets the concentration gradient on the BLM by exchanging 3 sodium
ions out of the cell and 2 potassium ions into the cell. NaK – Na-K-ATPase, Na+ - sodium, K+ –
potassium, Glc – glucose, Gln - glutamine.
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CHAPTER 3
ESTABLISHING AN ETHANOL DOSE
The initial steps of this dissertation required establishing the best dosage of ethanol. A
range of ethanol dosages, between a 0.02% and a 0.08% BAC were tested, as few studies have
examined the effect of ethanol at or below the legal limit in the United States. We determined
that one and three hours of the equivalent of a 0.02% BAC dosage of ethanol significantly
decreased glutamine uptake in IEC-18 cells (Figure 5; 1265±55.9 pmol/mg protein•min in
controls vs 793±70.0 ethanol-treated cells at 1-hour, p<0.01, n=4). The methods for this
procedure are described in chapter 4.

Figure 5: A dosage of ethanol equivalent to a 0.02% BAC significantly decreased sodiumdependent glutamine uptake in IEC-18 cells after one and three hours (*, p<0.01, n=4).
Error bars represent the standard error of the mean (SEM). The p-values were adjusted for
multiple hypotheses using a Bonferroni correction (1H: p<0.01; 3H: p<0.01).
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Furthermore, a dosage of ethanol equivalent to a 0.04% BAC significantly decreased
glutamine uptake (Figure 9; 1285±37 pmol/mg protein•2 min in controls vs 874±75 in ethanoltreated cells at 1-hour, p<0.01, n=6). A dosage equivalent to a 0.08% BAC significantly
decreased glutamine uptake in IEC-18 cells as well (Figure 6; 1213±52.7 pmol/mg protein•min
in controls vs 778.5±67.8 in ethanol-treated cells at 1-hour, p<0.05, n=4).

Figure 6: A dosage of ethanol equivalent to a 0.08% BAC significantly decreased glutamine
uptake in IEC-18 cells at one and three hours (*, p<0.01, n=4). Error bars represent the SEM.
The p-values were adjusted for multiple hypotheses using a Bonferroni correction (1H: p=0.02;
3H: p<0.01).

Initially, it was important to investigate differing concentrations of ethanol on glutamine
uptake in IEC-18 cells to establish the proper dosage of ethanol and to ensure that this effect was
not concentration dependent. We determined that at one hour and three hours, 0.02%, 0.04% and
0.08% ethanol all had a significant inhibition on glutamine uptake in IEC-18 cells. A dosage
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equivalent to a 0.04% BAC was selected due to its translational applicability, as it is considered a
moderate dose of ethanol.
VALIDATION OF MODEL
Next, we established that this dosage of ethanol did not cause changes in cell viability
using LDH and trypan blue assays (Figure 14). We also ensured that ethanol itself was causing
this decrease in glutamine absorption, and not acetaldehyde, the primary toxic metabolite of
ethanol metabolism (Figure 10).
One question was left in order to fully validate this model: should the ethanol treatments
be on the apical or BLM? Ethanol is absorbed quickly along the duodenum, and the
concentration of ethanol used in these studies would not transit the full length of the small
intestine before being completely absorbed into the blood stream (Cederbaum 2012). Thus,
ethanol interacts with the ileum of the small intestine along the BLM of intestinal epithelial cells
(Bode and Bode 2003, Krenz and Korthuis 2012). Therefore, glutamine uptake studies were
conducted in transwells, using the same methodology as described previously, in order to see if
the effect of ethanol on the BLM differed from apical treatment of ethanol. The only difference
in the methodology used is that ethanol was solely administered on the BLM of IEC-18 cells
using transwells. Moderate ethanol treatment on the BLM of IEC-18 cells for one hour decreased
glutamine uptake (Figure 7; 1313±48.8 pmol/mg protein•min in controls vs 986.7±54.5 in
ethanol-treated cells at 1-hour, p<0.05, n=3).
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Figure 7: Moderate ethanol treatment on the BLM decreased glutamine uptake in IEC-18
cells (*, p<0.05, n=3). Error bars represent the SEM.

The percentage decrease between control and ethanol-treated cells on the luminal, or
apical, side (68.0% inhibition) did not significantly differ from cells treated on the BLM (75%
inhibition). Therefore, studies were conducted throughout this dissertation on the apical side, to
avoid the temporal and fiscal costs associated with transwell studies. At this point, we were able
to conduct experiments to elucidate the effect of moderate ethanol on glutamine and glucose
absorption in IEC-18 cells.
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Abstract
Malnutrition is common in chronic alcoholics. Glutamine is a conditionally essential
amino acid which is vital to maintain the health and integrity of the mammalian small intestinal
mucosa. Glutamine is absorbed via Na-dependent glutamine co-transport B0AT1 (SLC6A19)
located on the brush border membrane (BBM) of intestinal absorptive villus cells. How ethanol
may affect B0AT1 is unknown. Intestinal epithelial cells grown to confluency were exposed to
the equivalent of a 0.04% blood alcohol content (8.64 mM ethanol). Na-dependent 3H-glutamine
uptakes were done to determine B0AT1 activity. Na-K-ATPase activity was measured as Pi
release. Western blot and immunocytochemistry (ICC) analysis were performed with the
appropriate B0AT1 antibodies. Results: Ethanol significantly decreased B0AT1 activity at all
time points. The Na-K-ATPase provides the favorable Na-gradient for B0AT1 and its activity
was reduced by moderate ethanol at all time points. Kinetic studies showed that the mechanism
of inhibition of B0AT1 by ethanol was secondary to a decrease in the maximal rate of uptake
(Vmax) of glutamine without a change in the affinity (1/ Km) of B0AT1. Western blot studies
demonstrated a significant decrease in B0AT1 protein expression in the whole cell homogenate
and in the BBM. ICC studies showed a similar decrease in immunofluorescence intensity. This
decrease in glutamine absorption was likely mediated by protein kinase C (PKC). Conclusions:
Ethanol directly inhibits the absorption of glutamine in intestinal epithelial cells by decreasing
B0AT1 co-transporter numbers as well as by altering the Na-gradient possibly via PKC. Thus,
these studies indicate that malnutrition associated with alcohol consumption may be at the level
of the nutrient absorptive pathways of intestinal epithelial cells.
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Introduction
According to the National Institute on Alcohol Abuse and Alcoholism, over 15 million
adults in the United States have an alcohol use disorder. Chronic alcohol use, defined by binge
drinking five or more days per month, has many well documented negative consequences
including an increased risk for cancer, cardiovascular disease, liver disease and malnutrition
(Rehm, Baliunas et al. 2010, Organization 2018). This increased risk of malnutrition was
demonstrated in 1984, when studies conducted by the Veterans Health Administration
Cooperative Studies Program presented that patients with almost 50 percent of total energy
intake from alcohol were often malnourished despite adequate caloric intake (McClain, Barve et
al. 2011).
For some time, chronic alcoholics were considered to be malnourished due to suboptimal
dietary intake. However, researchers have determined that ethanol decreases the absorption of
essential vitamins along the small intestine (Bode and Bode 2003). The absorption of over 20
nutrients have been shown to be affected by chronic alcohol consumption which includes
proteins, carbohydrates, including glucose (Chang, Lewis et al. 1967, Dinda, Beck et al. 1975,
Dinda and Beck 1977, Dinda and Beck 1981), lipids (Pfeiffer, Schmidt et al. 1992) as well as
vitamins such as vitamin B12 (Bode and Bode 2003), and vitamin C (Guo, Wang et al. 2013).
Clearly, the effect of ethanol on nutrient absorption in chronic alcoholics has been well
characterized. However, few studies have examined the effect of ethanol on the individual
nutrient co-transporters that are responsible for absorbing these essential nutrients. Ethanol has
been shown to affect vitamin co-transporters, including the thiamine (Subramanya, Subramanian
et al. 2010), folate (Romanoff, Ross et al. 2007), riboflavin (Subramanian, Subramanya et al.
2013), and vitamin C co-transporters which leaves a substantial gap in knowledge surrounding
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ethanol’s effect on many other nutrient co-transporters along the small intestine (Guo, Wang et
al. 2013).
Furthermore, in over fifty years of alcohol and nutrition research, the effect of ethanol on
glutamine absorption in the small intestine has never been investigated. Glutamine is a
conditionally essential amino acid that is imperative for maintaining the health of the intestinal
mucosa (Pochini, Scalise et al. 2014). Glutamine is the primary source of energy for enterocytes
and has been shown to play an important role in maintaining the integrity of the mucosa during
gastrointestinal disorders like inflammatory bowel disease (Singh, Arthur et al. 2015, Singh,
Arthur et al. 2018). It was previously shown that the primary sodium-dependent glutamine cotransporter in the BBM of villus cells is B0AT1 (SLC6A19) (Talukder, Kekuda et al. 2008).
B0AT1 is an electrogenic transmembrane protein that functions as a secondary active cotransporter. Thus, B0AT1 moves sodium out of the cell and glutamine into the cell at a 1:1 ratio
along sodium’s concentration gradient (Pochini, Scalise et al. 2014). The concentration gradient
for B0AT1 is provided by the basolateral Na-K-ATPase. Once in the body, glutamine is used in a
variety of cell metabolism processes including as a substrate in the TCA cycle, gluconeogenesis,
lipogenesis and in the urea cycle (Curi, Lagranha et al. 2005).
In this study, we hypothesized that ethanol affects the absorption of glutamine via B0AT1
in the BBM of villus cells. To better understand the onset of alcohol-dependent malnutrition, we
focused our study on a moderate dose of ethanol, defined as the amount in two alcoholic
beverages per day for men and one for women, equivalent to a blood alcohol content (BAC) of
0.04%. Thus, the aim of the present study is to investigate the effect of a moderate dose of
ethanol on B0AT1 in rat intestinal epithelial cells.
.
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Methods
Cell culture
The immortalized non-malignant rat intestinal epithelial cell line IEC-18 (CRL-1589
American Type Culture Collection) was treated with 8.64 mM ethanol, the equivalent of a 0.04%
BAC dosage, directly into fresh medium for 1, 3, 6, or 12 hours. Control-treated cells were
exposed to the same volume of sterile water in fresh medium. Cells were cultured in Dulbecco’s
modified Eagle Medium (DMEM) (high glucose 4.5 g/l, sodium bicarbonate 3.7 g/l) containing 2
mM L-glutamine, 10% vol/vol bovine fetal serum, 0.02% insulin, and 0.25%-hydroxybutyric
acid in a humidified atmosphere of 10% CO2 at 37°C. Cells were grown to 4 days post
confluence as monolayers, only using cells between passages 5 and 20, until ethanol treatment.
Four days post confluent cells were used because the cells have the characteristics of mature
villus enterocytes at this point in their development. The medium was changed every 2 to 3 days.
Na-K-ATPase measurement
IEC-18 cells were grown and treated with ethanol as described above. Control and
ethanol-treated cells were washed twice with ice-cold PBS and cells were harvested by scraping.
The cells were sonicated and centrifuged at 8000 x g for 5 minutes. Inorganic phosphate (Pi)
formation in cellular homogenates was measured as indirect Na-K-ATPase activity as previously
described (Forbush 1983) and the activity was expressed as nanomoles of Pi released per
milligram protein per minute.
Uptake studies in IEC-18 cells
As previously described (Arthur, Coon et al. 2014), sodium-dependent uptakes were
conducted using Na-HEPES buffer (47 mM KCl, 1 mM MgSO4, 1.2 mM KH2PO4, 20 mM
HEPES, 125 mM CaCl2, and 130 mM NaCl; pH 7.4). Uptakes were performed with and without
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sodium using Na-HEPES and a buffer containing 130 mM TMA-Cl and Na-free HEPES. By
including the sodium-free condition, the passive diffusion of glutamine can be measured. Both
reaction buffers contained 200 µM of cold L-glutamine and 10 µCi 3H-L-glutamine. All
reactions were performed for exactly 2 minutes and stopped with ice-cold TMA-HEPES. The
cells were then placed in 5 mL scintillation fluid and kept overnight. Samples were measured in
a scintillation counter (LS 6500; Beckman Coulter, Fullerton, CA).
Protein quantification
Using the Bio-Rad DC protein assay kit (Hercules, CA), total protein was measured by
the Bradford method. Bovine serum albumin (BSA) was used as a standard.
Kinetics
Na-dependent glutamine uptakes were performed at 30 seconds at varying concentrations
of glutamine (0.1, 0.5, 1, 5, 10, 25, 75 and 100 mM) as described above. Uptake values were
evaluated by Michaelis-Menten kinetics using a non-linear regression data analysis using Prism 7
software (GraphPad, San Diego, CA).
Western blot studies
Cells for whole cell homogenates were treated, collected and centrifuged at 8000 x g at
4°C for 5 minutes. The resulting pellet was solubilized in RIPA buffer containing protease
inhibitors (Santa Cruz, CA). The cellular extracts in RIPA were rocked for at least one hour at
4°C and then centrifuged at 8000 x g at 4°C for 5 minutes. The resulting supernatant was
measured for protein content using a NanoDrop Spectrophotometer (Thermo Scientific). BBM
protein was collected, solubilized, and measured as described previously (Talukder, Kekuda et
al. 2008, Arthur, Singh et al. 2018). Proteins were separated on a 12% polyacrylamide gel and
transferred onto a polyvinylidene fluoride membrane. Membranes were blocked in 5% bovine
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serum albumin for 1 hour as previously described (Singh, Arthur et al. 2015, Singh, Arthur et al.
2018). Then, the membranes were incubated with rabbit polyclonal primary antibodies against
B0AT1 (Abcam 180516) at 1:500 dilution at 4°C overnight. Membranes were washed and
incubated with horseradish peroxidase-conjugated anti-rabbit secondary antibodies at 1:1000
dilution at room temperature for 1 hour. ECL-TM Western Blotting Detecting Reagent was used
to detect the immobilized proteins. Luminescence was detected and analyzed by densitometry
using a FluorChem M imager (ProteinSimple). All blots were stripped and re-probed with a
mouse monoclonal primary antibody against ezrin (MilliporeSigma MAB3822-C) at 1:1000
dilution as above, and proteins were normalized against the ezrin values.
Immunocytochemistry (ICC)
Cells grown on glass coverslips were fixed with ice-cold methanol for 4 minutes. Nonspecific binding of primary antibodies was blocked using 5% BSA and 0.1% Triton-X for 1 hour
at room temperature. Cells were then washed in room temperature PBS 3 times for 5 minutes
each and incubated with B0AT1 primary antibody (Abcam 180516) at 1:250 dilution for 1-hour.
Cells were washed as before then incubated with goat anti-rabbit Alexa Fluor 594 secondary
antibody (Invitrogen, Eugene, OR) for 1 hour. Cells were washed again, mounted with
Fluoroshield Mounting Medium with DAPI (Abcam) and imaged using a 20X objective on an
EVOS FL Auto 2 microscope (Invitrogen) and quantified with Alpha View version 3.4.0.0.
siRNA transfections
Predesigned RNA silence for a negative control (ThermoFisher AM4635) and protein
kinase C (PKC) (ThermoFisher s128272 and s128273) were used for siRNA transfections.
Individual siRNAs (1.5 µg each) were suspended in a nucleofector solution (pH 7.4, 7.1 mM
ATP, 11.6 mM MgCl2.6H2O, 13.6 mM NaHCO3, 84 mM KH2PO4 and 2.1 mM glucose). Using
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IEC-18 cells, both negative controls and PKC siRNA was nucleofected into IEC-18 cells using a
Nucleofector II device (Amaxa) according to the manufacturer’s instructions. Cells were grown,
treated and used for experiments as previously described.
Statistical analysis
Each number (n) for any set of experiments refers to cell preparations from different
passages. Data were computed in triplicate and means ± standard error were evaluated. P-values
were derived by unpaired t-tests using Prism 7 software (GraphPad, San Diego, CA).
Experiments using more than one timepoint had their p-value adjusted for multiple hypotheses
using a Bonferroni correction. A p-value of less than 0.05 was considered statistically significant.
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Results
Effect of ethanol on sodium-dependent glutamine uptake in IEC-18 cells
To determine if ethanol effects glutamine absorption, 3H-glutamine uptake was done in
IEC-18 cells. Sodium-dependent glutamine uptake was decreased in 4 days post confluent IEC18 cells at the 1, 3, 6, and 12-hour timepoints (Figure 8; 1285±37 pmol/mg protein•2 min in
controls vs 874±75 in ethanol-treated cells at 1-hour, p<0.01, n=6).

Figure 8: Moderate ethanol decreased glutamine absorption in IEC-18 cells (*, p<0.05,
n=6). Error bars represent the SEM (1H: p<0.01; 3H: p<0.01; 6H: p=0.03; 12H: p<0.01).

Effect of acetaldehyde on glutamine uptake in IEC-18 cells
The primary toxic metabolite of ethanol metabolism is acetaldehyde, which at even
extremely low levels can cause cellular damage (Fisher, Swaan et al. 2010). To determine
whether this decrease in glutamine absorption is due to acetaldehyde’s action, 15 µM
acetaldehyde was added directly to the cell culture medium of IEC-18 cells for 1-hour. A
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commercial kit (Bioassays Systems) was used to determine the minimum concentration of
acetaldehyde following ethanol treatment in IEC-18 cells. Glutamine uptake does not change
following exposure to 15 µM acetaldehyde, suggesting that ethanol, not acetaldehyde, is the
primary cause for the decrease in Na-dependent glutamine absorption (Figure 9; 1082±71.9
pmol/mg protein•2 min in control vs 1067±37.3 in ethanol-treated cells at 1-hour, p>0.05, n=4).

Figure 9: Acetaldehyde did not alter 3H-glutamine uptake in IEC-18 cells (n=4). Error bars
represent the SEM.

Effect of ethanol on Na-K-ATPase activity in IEC-18 cells
The Na-K-ATPase located on the basolateral membrane (BLM) provides the transcellular
sodium gradient necessary for sodium-dependent nutrient co-transporters. Na-K-ATPase activity
was significantly inhibited by ethanol at all timepoints (Figure 10; 22.750±1.832 nmol/mg
protein•min in controls vs 10.667±1.031 in ethanol-treated cells at 1-hour, p<0.01, n=6). There
was no recovery in the Na-K-ATPase activity between the 1 and 12-hour time conditions.
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Figure 10: Moderate ethanol decreased Na-K-ATPase activity in IEC-18 cells (*, p<0.05,
n=6). Error bars represent the SEM (1H: p<0.01; 3H: p<0.01; 6H: p<0.01; 12H: p<0.01).

Effect of ethanol on the kinetic parameters of sodium-dependent glutamine cotransport in IEC-18 cells
The effect of ethanol on Na-K-ATPase activity as well as sodium-dependent glutamine
uptake was fairly linear over the 1 to 12-hour timepoints. Therefore, kinetic studies were
conducted at one hour. Kinetic studies showed that the mechanism of inhibition of sodiumdependent glutamine co-transport in IEC-18 cells after 1-hour exposure to ethanol was secondary
to a reduction in the maximal rate of uptake (Vmax) of the co-transporter without a change in the
affinity of the co-transporter (Km) (Table 4). These studies indicate that the mechanism of
inhibition of sodium-dependent glutamine co-transport in IEC-18 cells is likely secondary to
reduced co-transporter number.
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Table 4: In IEC-18 cells, the maximal rate of uptake (Vmax) of sodium-dependent glutamine
co-transport was significantly reduced when exposed to 1-hour of ethanol (*, p<0.01, n=4).

Quantitation of B0AT1 protein expression in IEC-18 cells exposed to ethanol
To determine the effect of ethanol on B0AT1 protein expression, Western blot analysis
was performed on whole cell homogenates. The protein expression of B0AT1 in whole cell
homogenates was significantly decreased in IEC-18 cells after 1-hour of ethanol treatment
(Figure 11A) which was confirmed by densitometric quantitation (Figure 11B; ethanol-treated
cells were 0.78 of controls, p<0.05, n=6).
B0AT1 is localized to the BBM of small intestinal enterocytes and therefore, Western
blots using BBM were conducted. B0AT1 protein expression levels were decreased in the BBM
of IEC-18 cells exposed to 1-hour of ethanol (Figure 11C), again confirmed by densitometric
quantitation (Figure 11D; ethanol-treated cells were 0.81 of controls, p<0.01, n=4). These data,
along with the kinetic analysis above, demonstrated that the mechanism of ethanol-mediated
sodium-dependent glutamine co-transport inhibition is secondary to a decrease in B0AT1 protein
expression in IEC-18 cells in the BBM.
In addition, ICC studies were performed in control and ethanol-treated IEC-18 cells
exposed to 1-hour of ethanol. Consistent with the Western blot data above, B0AT1
immunofluorescence intensity was significantly decreased in cells exposed to ethanol (Figure
12A, 12B).
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Figure 11: Ethanol decreased the protein expression of B0AT1 in IEC-18 cells. A) Western
blot analysis of B0AT1 protein expression in the whole cell homogenates from control and
ethanol-treated cells. The blots show a representative sample used for densitometric
quantification. B) Densitometric quantification of B0AT1 protein expression was significantly
decreased in whole cell homogenates after 1-hour exposure of ethanol (*, p<0.05, n=6). C)
Western blot analysis of BBM B0AT1 protein expression from control and ethanol-treated cells.
The blots show a representative sample used for densitometric quantification. D) Densitometric
analysis of B0AT1 protein expression was significantly decreased in the BBM fraction after 1hour exposure of ethanol (*, p<0.05, n=4). Error bars represent the SEM. Blots were normalized
with an anti-ezrin antibody to assure equivalence of loading.
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Figure 12: One hour of ethanol significantly decreased B0AT1 immunofluorescence
intensity. A) The pictures are a representative image taken at the 60X objective. The green stain
represents B0AT1. B) One hour of ethanol significantly decreased B0AT1 immunofluorescence
intensity in IEC-18 cells (*, p<0.05, n=4). Each sample is an average of 5 different images
obtained using a 20X objective. Error bars represent the SEM.

The effect of PKC-silencing on glutamine absorption in IEC-18 cells exposed to
ethanol
PKC has been shown to affect nutrient co-transport in IEC-18 cells (Arthur and
Sundaram 2014). Furthermore, the function of PKC has been shown to be altered in response to
ethanol as well (Stubbs and Slater 1999). Therefore, in order to elucidate a possible mechanism
of action for ethanol on B0AT1, PKC expression was selectively silenced in IEC-18 cells. In
PKC siRNA-transfected IEC-18 cells, ethanol does not affect Na-dependent glutamine
absorption (Figure 13; 1174.7±47.1 pmol/mg protein•2 min in control vs 732.7±118.9 in ethanol69

treated cells at 1-hour, p<0.05; 1147.7 pmol/mg protein•2 min in control+siRNA vs 1252.3±77.9
in ethanol-treated+siRNA cells at one hour, p>0.05, n=3) which indicated that PKC is likely
important in the ethanol-mediated inhibition of B0AT1.

Figure 13: Transfection with PKC-siRNA in IEC-18 cells reverses the ethanol-mediated
inhibition of sodium-dependent glutamine absorption (*, p<0.05, n=3).

Discussion
Chronic alcoholics are commonly malnourished, which is in part due to a suboptimal
diet, but may also be due to ethanol-mediated decreased absorption of various vitamins in the
small intestine including thiamine (Hoyumpa, Breen et al. 1975, Hoyumpa 1980, Hoyumpa,
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Patwardhan et al. 1981), folate (Hamid, Wani et al. 2007, Thakur, Rahat et al. 2015), riboflavin
(Subramanian, Subramanya et al. 2013), glucose (Dinda, Beck et al. 1975, Dinda and Beck 1977,
Dinda and Beck 1981), and minerals (Bode and Bode 2003). However, how ethanol affects the
absorption of the amino acid glutamine has not yet been investigated. In this study, it was
demonstrated that administration of a moderate dose of ethanol, equivalent to a 0.04% BAC,
significantly decreased sodium-dependent glutamine uptake by affecting the B0AT1 cotransporter directly. This is the first report of a decrease in glutamine absorption in response to
ethanol.
In this study, we showed that a moderate dose of ethanol decreases sodium-dependent
glutamine absorption in IEC-18 cells by decreasing the activity of the primary means of
assimilation of glutamine, namely, the Na-glutamine co-transporter B0AT1. The decrease in
B0AT1 was not secondary to diminished cell viability. Further, the effect was secondary to
ethanol and not its more toxic metabolite, acetaldehyde. At the cellular level, the inhibition of
B0AT1 by moderate ethanol was secondary to both an effect at the level of the co-transporter in
the BBM as well as secondary to diminished Na-extruding capacity of the cell. At the level of the
co-transporter, the mechanism of inhibition of B0AT1 was secondary to a decrease in the
maximal rate of uptake of glutamine (Vmax) without a change in the affinity of the co-transporter
for glutamine. Molecular studies demonstrated that BBM levels of B0AT1 were reduced by
moderate ethanol. Finally, this inhibition of B0AT1 by ethanol appears to be mediated by the
PKC pathway in intestinal epithelial cells.
In this study, moderate ethanol decreased the protein expression of B0AT1 in whole cell
homogenate and in the BBM. Similar to our study, Subramanya and colleagues have shown that
the protein expression levels of vitamin co-transporters are decreased by ethanol. Thiamine co-
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transport was also shown to be decreased along the jejunal BBM and BLM by a reduction in the
protein and mRNA expression of thiamine transporter-1, but not thiamine transporter-2, after
male Wistar rats were exposed to the Lieber-DeCarli ethanol liquid diet (36% calorically
ethanol) for 2, 4, and 6 weeks (Subramanya, Subramanian et al. 2010). Furthermore, in another
study, the vitamin B2 (riboflavin) transporters 1 and 3 mRNA and protein expression were
decreased when Wistar rats were fed a Lieber-DeCarli ethanol liquid diet for four weeks
(Subramanian, Subramanya et al. 2013). The results of our present study are consistent with
these previous reports and thus furthering the current knowledge on ethanol-dependent
malnutrition.
This study demonstrated that there was a decrease in the Na-K-ATPase activity in IEC-18
cells exposed to moderate ethanol. The Na-K-ATPase is vital in establishing the sodium gradient
necessary for all sodium-dependent nutrient co-transporters to function at optimal levels. By
decreasing the activity of the Na-K-ATPase, ethanol may decrease BBM glutamine co-transport
by affecting the sodium gradient necessary for this co-transporter to properly function. Other
studies have investigated the effect of ethanol on Na-K-ATPase activity and found that acute
doses of ethanol decreased the activity of the Na-K-ATPase, but chronic doses of ethanol
increased its activity (Rodrigo and Thielemann 1997, Otis, Mitchell et al. 2008, Rasic-Markovic,
Krstic et al. 2008). In all, while ethanol clearly has a wide range of effects on the Na-K-ATPase,
the effect of moderate ethanol on the BLM Na-K-ATPase appears to have a role in regulating
Na-dependent nutrient assimilation by enterocytes.
This study, for the first time, showed the unique regulation of the glutamine absorption by
a moderate dose of ethanol, specifically through decreased protein expression of B0AT1 in IEC18 cells. The intracellular regulation of this observation has yet to be fully elucidated. However,
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initial mechanistic studies, using siRNA-transfected IEC-18 cells, demonstrated that PKC has a
regulatory role in this process. It has previously been shown that PKCα can regulate the sodium
alanine co-transporter ASCT1 in intestinal epithelial cells (Arthur and Sundaram 2014). PKC has
also been shown to alter the function of the Na-K-ATPase (Bibert, Roy et al. 2008) and ion
channels in response to ethanol in a wide variety of studies. Ion channels altered by ethanol via
PKC include the metabotropic glutamate receptor, the BK-channel, and the GABA chloride
channel (Stubbs and Slater 1999). Thus, in our study and in the literature, there is a clear link
between ethanol, PKC, and Na-nutrient co-transporters. However, further studies are required to
fully elucidate the mechanism of action between ethanol, B0AT1 and PKC.
In conclusion, the sodium-dependent glutamine co-transporter, B0AT1, was significantly
reduced by moderate ethanol in intestinal epithelial cells. The mechanism of inhibition was due
to a decrease in the number of BBM co-transporters as well as well as a diminished sodium
gradient set by the Na-K-ATPase. Furthermore, the PKC pathway likely mediates this inhibition
of B0AT1 by moderate ethanol which provides evidence that even moderate doses of ethanol
affects important nutrient uptake pathways in intestinal epithelial cells which may contribute to
alcohol-mediated malnutrition in alcoholics and has implications on the treatment of malnutrition
in chronic alcoholics.
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Abstract
Chronic alcohol use often leads to malnutrition. However, how the intestinal absorption
of nutrients like glucose may be affected during moderate ethanol use has not been investigated.
Glucose is absorbed via sodium-dependent glucose co-transport (SGLT1; SLC5A1) along the
brush border membrane (BBM) of intestinal absorptive villus cells. Rat intestinal epithelial cells
(IEC-18) were exposed to 8.64 mM ethanol over 1, 3, 6, and 12 hours. Sixteen-week-old Sprague
Dawley rats were administered 2 g/kg ethanol over 1, 3, and 6 hours. Sodium-dependent 3H-Omethyl-D-glucose uptake was performed to determine SGLT1 activity. Na-K-ATPase activity
was measured as a function of inorganic phosphate release. Protein expression was analyzed by
Western blot analysis and immunohistochemical staining. Ethanol significantly decreased Nadependent glucose absorption and Na-K-ATPase activity in enterocytes in vitro and in vivo.
Kinetic studies showed that the mechanism of inhibition of Na-glucose co-transport was
secondary to a decrease in the affinity (1/Km) of the co-transporter for glucose both in vitro and
in vivo. Western blots and immunohistochemistry further demonstrated unaltered SGLT1 levels
after ethanol treatment. In conclusion, moderate ethanol significantly decreases glucose
absorption in enterocytes in vitro and in vivo. The inhibition of SGLT1 is secondary to altered
Na-gradient at the cellular level and secondary to diminished affinity of the co-transporter for
glucose at the protein level in the BBM. These observations may, at least in part, explain the
malnutrition associated with alcohol consumption.
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Introduction
Chronic alcohol use has many well documented negative consequences including an
increased risk of liver disease, cirrhosis, cancer, high blood pressure and stroke (Rehm, Baliunas
et al. 2010, Organization 2018). Perhaps the most well-known but least understood complication
of chronic alcoholism is malnutrition. In fact, how even moderate alcohol consumption, a
considerably more common occurrence, may affect nutrient absorption in the mammalian small
intestine is not fully understood. According to the 2015 National Survey on Drug Use and
Health, almost 90% of adults report alcohol consumption during their lifetime. Moderate alcohol
use, defined as one standard alcoholic beverage per day for women and two for men, imparts
surprising health benefits including decreased risk for heart disease, ischemic stroke, diabetes,
and obesity (NIAAA, Prevention). Nevertheless, beneficial or deleterious, how ethanol may
affect intestinal nutrient absorption is poorly understood.
Chronic use of alcohol leads to malnutrition in chronic alcoholics, in part due to
suboptimal nutrient intake (Lieber 2003). Alcohol use decreases absorption of essential vitamins
along the small intestine including vitamin B12, vitamin B6, vitamin C, and selenium (Bode and
Bode 2003). It also decreases the absorption of vitamin B1 (thiamine) (Subramanya,
Subramanian et al. 2010), vitamin B2 (riboflavin) (Subramanian, Subramanya et al. 2013), and
folate (Hamid, Wani et al. 2007) at the level of the nutrient co-transporter in the brush border
membrane (BBM) of enterocytes. While the effect of ethanol on vitamin assimilation has been
studied more often, its effect on nutrient absorption is less well understood. This study, for the
first time, investigates alcohol’s effect on nutrient absorption; specifically, the effect of moderate
ethanol on the Na-dependent glucose co-transporter, SGLT1, complementarily in vitro and in
vivo.
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Glucose is a primary fuel source for the body. The primary means of absorption in the
mammalian small intestine for glucose is via the Na-dependent glucose co-transporter SGLT1
(SLC5A1). SGLT1 is localized in the BBM of the villus, but not crypt cells, in the mammalian
small intestine. SGLT1 is a 14-transmembrane domain protein, which is mainly expressed in the
intestine. It facilitates the movement of two sodium ions into the cell with one glucose molecule
(2:1 ratio). The favorable sodium gradient for SGLT1 in villus cells is provided by the
basolateral membrane (BLM) Na-K-ATPase. Additionally, there is emerging evidence that
SGLT1 regulates the other primary Na-absorptive mechanism in intestinal enterocytes via the
sodium-proton exchanger NHE3 (Coon, Kekuda et al. 2008), (Lehmann and Hornby 2016).
Once glucose is absorbed into enterocytes, it can be transported and stored in the body to
be used in a variety of metabolic processes including the pentose phosphate pathway and the
Krebs cycle to produce energy in the form of adenosine triphosphate (Lehmann and Hornby
2016). Dysregulation of glucose absorption along the small intestine can lead to a variety of
metabolic diseases, including malnutrition (Lieber 2003).
Previous studies have investigated the role of ethanol on glucose absorption. Overall,
glucose absorption was significantly decreased by ethanol in hamsters (Dinda, Beck et al. 1975,
Dinda and Beck 1977, Dinda and Beck 1981), rats (Cobb, Van Thiel et al. 1983, al-Balool and
Debnam 1989, Kaur, Kaur et al. 1995), chickens (Yunus, Awad et al. 2011), and dogs (Money,
Petroianu et al. 1990). However, none of these studies investigated the effect of moderate ethanol
on the sodium-dependent glucose co-transporter, SGLT1.
In this study, we aim to investigate the effect of a moderate dose of ethanol on SGLT1 in
vitro and in vivo to better understand alcohol-dependent malnutrition.
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Methods
Cell culture
The immortalized non-malignant rat intestinal epithelial cell line IEC-18 (CRL-1589
American Type Culture Collection) was cultured in Dulbecco’s modified Eagle Medium
(DMEM) (high glucose 4.5 g/l, sodium bicarbonate 3.7 g/l) containing 2 mM L-glutamine, 10%
vol/vol bovine fetal serum, 0.02% insulin, and 0.25%-hydroxybutyric acid in a humidified
atmosphere of 10% CO2 at 37°C. The medium was changed every 2 to 3 days. Cells were grown
to 4 days post confluence as monolayers, only using cells between passages 5 and 20. Cells were
treated with 8.64 mM ethanol (200 proof, Pharmco Apper), the equivalent of a 0.04% blood
alcohol content (BAC) dosage, directly into fresh medium for 1, 3, 6, or 12 hours. Controltreated cells were exposed to the same volume of sterile water in fresh medium.
Lactate dehydrogenase (LDH) assays
Control and ethanol-treated cells were tested with a colorimetric LDH assay kit
(Abcam) as per kit instructions to determine cell viability.
Trypan blue exclusions
Control and ethanol-treated cells were washed with pre-warmed 1X phosphate buffered
saline (PBS), and then harvested using 0.05% trypsin in PBS for 5 minutes at 37°C. Cell
suspensions were mixed 1:1 with trypan blue solution (MilliporeSigma), and the stained cells
were immediately counted with a hemocytometer.
Uptake studies in IEC-18 cells
Uptake studies were performed as previously described (Arthur, Coon et al. 2014) in
IEC-18 cells. In brief, sodium-dependent uptakes were conducted using Na-HEPES buffer (47
mM KCl, 1 mM MgSO4, 1.2 mM KH2PO4, 20 mM HEPES, 125 mM CaCl2, and 130 mM NaCl;
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pH 7.4). To exclude passive uptake from active transport processes, specific reaction mixtures
were used. Glucose uptakes were performed with and without 1 mM phlorizin, an SGLT1
inhibitor, and 100 µM of cold D-glucose. Both reaction buffers contained 10 µCi 3H-3-Omethyl-D-glucose (OMG) and 10 mM OMG-glucose. The reaction was stopped with ice-cold
Na-HEPES buffer containing 25 mM D-glucose. Na/H uptakes were performed using 10 µCi
22

Na with and without 50 µM EIPA, a Na/H exchanger inhibitor. The reaction was stopped with

ice-cold TMA-HEPES. All reactions were performed for exactly 2 minutes. The cells were then
processed as previously described (Arthur, Singh et al. 2018) and measured in a scintillation
counter (LS 6500; Beckman Coulter, Fullerton, CA).
Protein quantification
Total protein was measured by the Bradford method, using the Bio-Rad DC protein assay
kit (Hercules, CA) with bovine serum albumin (BSA) as a standard.
Na-K-ATPase measurement
Isolated villus cells from rats were homogenized and centrifuged at 8000 x g for 5
minutes. The Na-K-ATPase activity was measured as inorganic phosphate (Pi) formation in
cellular homogenates as previously described (Forbush 1983) and activity was expressed as
nanomoles of Pi released per milligram protein per minute.
Animal studies
Thirteen to fifteen-week-old male Sprague Dawley (SD) rats (001) were purchased from
Charles River and allowed to acclimate to their environment for at least 1 week. All rats had
equal access to normal chow and water and were kept in a 12-hour light and dark cycle. All oral
gavage procedures started between 7 and 10 AM when the rats had aged to 16 weeks. An oral
intragastric gavage was used with manual restraint, and 2 g/kg ethanol or tap water was
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administered to ethanol-treated rats or control-treated rats, respectively (Livy, Parnell et al.
2003). At the 3 and 6-hour time points, blood for plasma separation for BAC measurement was
collected via tail nick. Rats in the 6-hour treatment group were administered a second dose of
ethanol 3 hours after the first dosage to maintain the correct BAC. Animals were euthanized with
excess CO2, and a final blood sample for plasma separation was collected via cardiac puncture.
BAC was measured using an AM1 Alcohol Analyzer (Analox) and the respective Analox kit
instructions. All animal handling, treatment, and euthanasia were carried out according to a
protocol approved by the Marshall University IACUC.
Villus cell isolation
Villus cells were isolated from control and ethanol-treated rats from the ileal small
intestine by a Ca+2 chelation technique as previously described (Sundaram, Knickelbein et al.
1991). Briefly, a 12-inch section of the distal small intestine was filled with a buffer containing
0.15 mM EDTA, 112 mM NaCl, 25 mM NaHCO3, 2.4 mM K2PO4, 0.4 mM KH2PO4, 2.5 mM Lglutamine, 0.5 mM β-hydroxybutyrate, and 0.5 mM dithiothreitol, and gassed with 95% O2 and
5% CO2, pH 7.4 at 37°C. The intestine was incubated for 3 minutes and palpitated for 3 minutes
to aid in cell dispersion. The resulting cell suspension was then used for whole cell uptakes, or
phenyl-methyl sulfonyl fluoride was added and centrifuged at 100 x g for 3 minutes, and the
cellular pellet was frozen immediately in liquid nitrogen and stored at -80°C for future use.
Uptake studies in villus cells from rats
Intact whole cell uptakes were conducted (100 mg wet weight) immediately following the
villus cell isolation. Cells were washed and suspended in the 37°C Na-HEPES buffer described
above. In room temperature vials, 100 µL of the previously described reaction mixtures were
added to 100 µL of the cellular suspension. The uptake was halted at exactly 2 minutes with ice-
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cold stop solution as described above. The mixture was filtered on 0.65 µm mixed cellulose
esters membrane filters (DAWP; Millipore) and washed twice with ice-cold stop solution using
vacuum filtration. Each filter was dissolved in 5 mL scintillation solution, and radioactivity was
measured as above.
Brush border membrane vesicle (BBMV) preparation and uptake
BBMV from rat intestinal villus cells were prepared by CaCl2 precipitation and
differential centrifugation as previously described (Talukder, Kekuda et al. 2008, Arthur, Singh
et al. 2018). The final BBMV was incubated for an hour in a sodium-free buffer at room
temperature, and 5 µL of BBMV were incubated in 95 µL reaction buffer as described above.
The reaction was arrested at 90 seconds and filtered on a 0.45 µm mixed cellulose esters
membrane filters (HAWP; Millipore). Each filter was washed twice with ice-cold stop solution
using vacuum filtration, then dissolved in scintillation fluid, and measured as above.
Kinetics
Sodium-dependent glucose uptakes were performed at 30 seconds at varying
concentrations of glucose (0.1, 0.5, 1, 5, 10, 25, 75 and 100 mM) as described above. Uptake
values were evaluated by Michaelis-Menten kinetics using a non-linear regression data analysis
using Prism 7 software (GraphPad, San Diego, CA). Isolated rat villus cells were used to create
BBMVs and kinetics were performed as above.
Western blot studies
Whole cell homogenates were prepared by first centrifuging cells at 8000 x g at 4°C for 5
minutes and solubilizing the resulting pellet in RIPA buffer containing protease inhibitors (Santa
Cruz, CA). Cellular extracts in RIPA were then centrifuged at 8000 x g at 4°C for 5 minutes, and
the supernatant was measured for protein content using a NanoDrop Spectrophotometer (Thermo
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Scientific). Proteins from BBM preparations were solubilized and extracted in RIPA buffer as
above. Proteins were separated on a 12% polyacrylamide gel, transferred onto a polyvinylidene
difluoride membrane, blocked in 5% BSA for IEC-18 samples or 5% milk for SD rat samples for
1 hour as previously described (Singh, Arthur et al. 2015, Singh, Arthur et al. 2018). Rabbit
polyclonal primary antibodies against SGLT1 (Abcam 14686) were used at 1:500 dilution at 4°C
overnight. Horseradish peroxidase-conjugated anti-rabbit secondary antibodies at 1:1000 dilution
at room temperature for 1 hour were also used. ECL-TM Western Blotting Detecting Reagent
detected the immobilized proteins. Luminescence was detected and analyzed by densitometry
using a FluorChem M imager (ProteinSimple). All blots were stripped, and re-probed with a
mouse monoclonal primary antibody against ezrin (MilliporeSigma MAB3822-C) at 1:1000
dilution as above, and proteins were normalized against the ezrin values.
Immunocytochemistry (ICC)
Control and ethanol-treated cells grown on glass coverslips were fixed with ice-cold
methanol for 4 minutes. Non-specific binding of primary antibodies was blocked using 5% BSA
and 0.1% Triton-X for 1 hour at room temperature. Cells were then washed in room temperature
PBS, 3 times for 5 minutes each and incubated with SGLT1 primary antibody (Abcam 14686) at
a 1:250 dilution for 1-hour. Cells were washed as before, then incubated with goat anti-rabbit
Alexa Fluor 594 secondary antibody (Invitrogen, Eugene, OR) for 1 hour at a 1:500 dilution. The
cells were washed again, mounted with Fluoroshield Mounting Medium with DAPI (Abcam) and
imaged using a 20X objective on an EVOS FL Auto 2 microscope (Invitrogen) and quantified
with AlphaView software version 3.4.0.0.
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Immunohistochemistry (IHC)
A half inch of terminal ileum was separated for IHC. The ileum was gently washed with
room temperature PBS, then flash frozen using liquid nitrogen and stored at -80°C until
processing. Upon use, samples were quickly placed in Tissue Plus O.C.T. Compound (Fisher
HealthCare) and frozen using dry ice in methanol to avoid thawing the sample. Samples were
sectioned 3 µm thick at -20°C using a cryostat. Sections were fixed in -20°C methanol for 30 sec
and processed with the same blocking, primary and secondary antibodies used above. Tissue
sections were mounted, imaged and analyzed as above.
Statistical analysis
Data were computed in triplicate and mean ± standard error were evaluated. P-values
were derived by unpaired t-test. In cases of multiple time points, multiple hypothesis testing was
addressed with a Bonferroni correction using Prism 7 software (GraphPad, San Diego, CA). A pvalue of less than 0.05 was considered statistically significant. To check for the robustness of the
data sets, non-parametric methodology was used. Each number (n) for any set of experiments
refers to cell preparations from different passages.
Results
Cell viability in response to a moderate dosage of ethanol in IEC-18 cells
Ethanol has been shown to be toxic to cells at high concentrations (Goldstein 1987). To
ensure that our dosage of moderate ethanol (8.64 mM or the equivalent of a 0.04% BAC), was
not cytotoxic, LDH and trypan blue exclusion experiments were performed. This dose of ethanol
did not cause cell damage or death over 1, 3, 6, and 12 hours (Figure 14A, B). In the LDH assay,
ethanol-treated cells did not significantly differ from controls (ethanol-treated cells were
98.6±0.6% of controls, p>0.05, n=4). In trypan blue assays, ethanol-treated cells did not
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significantly differ from controls (98.5±1.0% in controls vs 97.6±0.3% in ethanol-treated cells at
1 hour, p>0.05, n=4). Cell survival between 95-100% are considered within normal
physiological parameters.

Figure 14. Moderate ethanol (8.64 mM) does not significantly decrease cell viability in IEC18 cells. A) Ethanol does not cause significant cell death in IEC-18 cells using an LDH assay.
For LDH assays, ethanol-treated cells were normalized to control-treated cells (1H: p=0.20; 3H:
p=0.24; 6H: p=2.00; 12H: p=0.20; n=4). B) Ethanol does not cause significant cell death in IEC18 cells using trypan blue assays (1H: p=1.07; 3H: p=3.17; 6H: 2.15; 12H: p=3.37; n=4). Error
bars represent the standard error of the mean (SEM).
Effect of ethanol on sodium-dependent glucose uptake in IEC-18 cells
To determine if moderate ethanol affects glucose absorption, 3H-OMG uptakes were
conducted in IEC-18 cells exposed to 1, 3, 6 and 12 hours of ethanol. Ethanol significantly
decreased sodium-dependent glucose absorption at all time points (Figure 15; 502±27.3 pmol/mg
protein•2 min in control vs 243±13.5 in ethanol-treated cells at 1-hour, p<0.01, n=6).
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Figure 15: Moderate ethanol decreased glucose absorption in IEC-18 cells. Na-dependent
glucose uptake was determined as a function of phlorizin-sensitive 3H-OMG uptakes in the
presence and absence of moderate ethanol (*, 1H: p<0.01; 3H: p<0.01; 6H: p=0.04; 12H:
p=0.03; n=6). Error bars represent the SEM.
Effect of ethanol on Na-K-ATPase activity in IEC-18 cells
The Na-K-ATPase located on the BLM provides the transcellular sodium gradient
necessary for sodium-dependent nutrient co-transporters. The Na-K-ATPase activity was
significantly inhibited by moderate ethanol at all time points (Figure 16; 22.1±1.76 nmol/mg
protein•min in control vs 8.17±0.95 in ethanol-treated cells at 1-hour, p<0.01, n=6).
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Figure 16: Moderate ethanol significantly decreased Na-K-ATPase activity in IEC-18 cells.
The Na-K-ATPase activity was determined as a function of Pi release in the presence and
absence of moderate ethanol (*, 1H: p<0.01; 3H: p<0.01; 6H: p=0.01; 12H: p<0.01; n=6). Error
bars represent the SEM.
Effect of acetaldehyde on glucose uptake in IEC-18 cells
Ethanol is metabolized into acetaldehyde, which can cause cell damage by forming
adducts with other molecules, like lysine, at concentrations as low as 5 µM (Fisher, Swaan et al.
2010). Thus, it was determined how much acetaldehyde was produced in response to one hour of
ethanol treatment in IEC-18 cells using a commercially available kit (Bioassays systems).
Approximately 11 µM acetaldehyde was measured in IEC-18 cells following one hour of ethanol
exposure (data not shown). Then, in a separate experiment, acetaldehyde was added directly to
the cell culture medium of IEC-18 cells for one hour (15 µM) to determine if acetaldehyde
affects SGLT1 activity. There was no change in sodium-dependent glucose uptake following
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exposure to 15 µM acetaldehyde (Figure 17; 539±50.2 pmol/mg protein•2 min in control vs
533±52.9 in acetaldehyde-treated cells at 1-hour, p>0.05, n=4).

Figure 17: Acetaldehyde (15 µM) did not affect glucose absorption in IEC-18 cells. Nadependent glucose uptake was determined as a function of phlorizin-sensitive 3H-OMG uptakes
in the presence and absence of acetaldehyde (n=4). Error bars represent the SEM.
Effect of ethanol on Na/H exchange in IEC-18 cells
Sodium-dependent glucose co-transport and Na/H exchange are the two major sodiumabsorptive pathways located on the BBM of intestinal epithelial cells. Further, the Na-K-ATPase
maintains the cellular sodium concentration which we established was decreased by ethanol in
IEC-18 cells. Thus, to investigate if ethanol also affects BBM Na/H exchange in IEC-18 cells,
we conducted 22Na-uptakes. We demonstrated that moderate ethanol did not change Na/H
exchange in IEC-18 cells (Figure 18; 1120±18.3 pmol/mg protein•2 min in control vs 1104±41.9
in ethanol-treated cells at 1-hour, p>0.05, n=4) which indicates that ethanol’s effect on Naabsorptive pathways in IEC-18 cells is selective.
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Figure 18: Ethanol did not alter Na/H exchange in IEC-18 cells. Na/H uptake was determined
as a function of 22Na uptake in the presence and absence of moderate ethanol (n=4). Error bars
represent the SEM.
Effect of ethanol on the kinetic parameters of sodium-dependent glucose cotransport in IEC-18 cells
Kinetic studies were conducted to determine the mechanism of inhibition of sodiumdependent glucose co-transport by moderate ethanol. The mechanism of inhibition of Na-glucose
co-transport in IEC-18 cells by ethanol was secondary to a decrease in the affinity of the cotransporter for glucose without a change in the maximal rate of uptake of the co-transporter
(Vmax), suggesting a decreased affinity of SGLT1 to glucose, rather than a reduction in cotransporter number (Table 5).
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Table 5: Effect of ethanol on the kinetic parameters of sodium-dependent glucose cotransport in rat intestinal epithelial cells in vitro and in vivo. Na-dependent glucose uptake
was determined by varying concentrations of glucose using phlorizin-sensitive 3H-OMG uptakes
in the presence and absence of moderate ethanol. Uptake for all concentrations was conducted at
30 seconds. In IEC-18 cells, the affinity of the sodium-dependent co-transporter SGLT1 was
decreased as represented by an increase in Km when exposed to 1 hour of ethanol (*, p<0.01,
n=4). In SD rats, the affinity of the sodium-dependent co-transporter SGLT1 was decreased,
represented by an increase in Km, when exposed to 1-hour of ethanol (*, p<0.01, n=3).
Quantification of SGLT1 protein expression following exposure to moderate ethanol
in IEC-18 cells
Western blot analysis of SGLT1 protein was performed on whole cell homogenates and
BBM preparations. Protein expression of SGLT1 in whole cell homogenates was not
significantly altered in IEC-18 cells after one-hour exposure to ethanol, as quantified by
densitometry (Figure 19 A-B; ethanol-treated cells were 0.98 of control, p>0.05, n=4). Similarly,
there was no difference in SGLT1 protein levels in IEC-18 cell BBM between control and
ethanol-treated IEC-18 cells (Figures 19 C-D; ethanol-treated cells were 1.04 of control, p>0.05,
n=4).
In addition, ICC studies were performed in control and ethanol-treated cells exposed to 1
and 12 hours of ethanol. Consistent with Western blot data, SGLT1 immunofluorescence
intensity was unchanged in cells exposed to ethanol (Figure 20 A-B).
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These data, along with the kinetic analysis above, demonstrate that the mechanism of
inhibition of ethanol-mediated sodium-dependent glucose co-transport in IEC-18 cells is via a
change in the affinity of SGLT1 for glucose and not through a change in the protein expression.

Figure 19: Ethanol did not change SGLT1 protein expression in IEC-18 cells. (A) Western
blot analysis of SGLT1 protein expression in whole cell homogenates from control and ethanoltreated cells. The blots show a representative sample used for densitometric quantification (n=4).
(B) Densitometric quantification of SGLT1 protein expression was not significantly changed in
whole cell homogenates after 1-hour exposure of ethanol (n=4). (C) Western blot analysis of
BBM protein expression of SGLT1 from control and ethanol-treated cells. The blots show a
representative sample used for densitometric quantification. (D) Densitometric analysis of
SGLT1 protein expression was not significantly altered in the BBM fraction after 1-hour
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exposure to ethanol (n=4). Error bars represent the SEM. Blots were normalized with an ezrin
antibody to assure equivalence of loading.

Figure 20: SGLT1 expression in IEC-18 cells after exposure to ethanol. (A) The effect of
ethanol on SGLT1 expression in IEC-18 cells imaged with the 20X objective. (B) One hour of
ethanol did not significantly change SGLT1 immunofluorescence intensity in IEC-18 cells (1H:
p=1.98; 12H: p=1.80; n=4). Each sample is an average of at least 5 different images obtained
using a 20X objective. The error bars represent the SEM.
Effect of a short-term oral gavage of ethanol in SD rats
To determine the in vivo effect of moderate ethanol consumption on SGLT1, SD rats
were utilized. Male rats, 16 weeks old, were administered ethanol by intragastric gavage. The
body weights of the rats at the time of gavage did not differ (Figure 21A). The BAC of the rats
was measured at the time of euthanasia or, in the longer time points, one hour after ethanol
administration. The rats achieved the equivalent of 0.04% BAC (Figure 21B).
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Figure 21: Establishment of the Sprague Dawley rat model using an oral gavage of ethanol.
(A) Body weights of 16-week old SD rats before oral gavage did not differ (1H: p=1.80; 3H:
p=0.99; 6H: p=2.31; n=4). (B) The administration of 2 g/kg ethanol achieved a BAC of 0.04% in
SD rats (*, 1H: p<0.01; 3H: p<0.01; 6H: p<0.01; n=4). The error bars represent the SEM.
Effect of ethanol on Na-glucose co-transport in intestinal epithelial cells in vivo
To determine if moderate ethanol affects glucose absorption in vivo, 3H-OMG uptakes
were conducted in villus cells isolated from rats exposed to 1, 3, and 6 hours of ethanol. Sodiumdependent glucose absorption was significantly decreased at all time points in ethanoladministered rats (Figure 22A; 122±8.67 pmol/mg protein•2 min in control vs 71.0±3.35 in
ethanol-treated rats at 1-hour, p<0.01, n=4).
Effect of ethanol on Na-K-ATPase activity in vivo
Intestinal epithelial cell Na-K-ATPase activity, as measured by the release of inorganic
phosphate, was also decreased in ethanol-treated rats at all time points in vivo (Figure 22B;
22.1±1.67 nmol/mg protein•min in control vs 9.3±0.72 in ethanol-treated rats at 1-hour, p<0.05,
n=4).
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Figure 22: An oral gavage of ethanol significantly decreased glucose absorption and
Na-K-ATPase activity in SD rats. (A) Whole villus cell phlorizin-sensitive 3H-OMG
uptakes decreased in SD rats exposed to ethanol (*, 1H: p<0.01; 3H: p=0.03; 6H: p<0.01;
n=4). (B) Ethanol decreased Na-K-ATPase activity in SD rats (*, 1H: p<0.01; 3H: p=0.01;
6H: p=0.01; n=4). The error bars represent the SEM.
Effect of ethanol on sodium-dependent glucose BBMV uptakes in SD rats
To determine if ethanol has a direct effect on Na-glucose co-transport in the BBM of the
villus cells, BBMVs were studied. Na-dependent glucose absorption was significantly decreased
in the BBMVs from ethanol-treated animals (Figure 23; 3.04±0.26 pmol/mg protein•90 secs in
control vs 1.28±0.19 in ethanol-treated rats, p<0.01, n=4).
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Figure 23: An oral gavage of ethanol significantly decreased BBMV 3H-glucose uptake in
SD rats. Na-dependent glucose uptake was determined as a function of phlorizin-sensitive 3HOMG uptakes in the presence and absence of moderate ethanol (*, p<0.01, n=4). The error bars
represent the SEM.
Effect of ethanol on the kinetic parameters of sodium-dependent glucose cotransport in SD rats
Kinetic studies were conducted in BBMVs from rats exposed to ethanol for one hour.
The mechanism of inhibition of sodium-dependent glucose co-transport in vivo was secondary to
a decrease in the affinity of the co-transporter for glucose (1/ Km) without a change in the
maximal rate of uptake of the co-transporter (Vmax) (Table 5), suggesting no reduction in SGLT1
co-transporter number, as seen in the previous in vitro studies.
Effect of in vivo ethanol consumption on SGLT1 protein expression in SD rats
To determine if moderate ethanol affects SGLT1 protein expression, Western blot
analysis was performed on whole cell homogenates. SGLT1 levels in the whole cell
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homogenates were not significantly altered in SD rats after one-hour exposure of ethanol, as
quantified by densitometry (Figure 24 A-B; ethanol-treated cells were 1.07 of control, p>0.05,
n=4). Since SGLT1 is a BBM protein, Western blot analysis of SGLT1 protein was performed in
the BBM as well. SGLT1 BBM immune reactive protein levels were not significantly altered in
SD rats after one-hour exposure of ethanol as quantified by densitometry (Figure 24 C-D;
ethanol-treated cells were 1.06 of control, p>0.05, n=4).
Next, IHC studies were performed in the small intestine of control and ethanol-treated
rats (Figure 25A). Quantification of immunofluorescence intensity showed that control-treated
rats did not significantly differ from ethanol-treated rats (Figure 25B). Furthermore, Na-KATPase immunofluorescence intensity also did not change between the control and ethanoltreated rats (Figure 25C).
Taken together, these molecular and kinetic data showed that ethanol, at a dosage
equivalent to a BAC of 0.04%, significantly inhibited SGLT1 through a decrease in the affinity
of the co-transporter without a change in the number of co-transporters in vivo which is directly
comparable to the previous in vitro studies in IEC-18 cells.
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Figure 24: An oral gavage of ethanol in SD rats did not change protein expression levels of
SGLT1. (A) Western blot analysis of SGLT1 protein expression in whole cell homogenates from
control and ethanol-treated SD rats. The blots show a representative sample used for
densitometric quantification. Separated control and ethanol samples were run on the same
membrane but were not located next to each other. (B) Densitometric quantification of SGLT1
protein expression was not significantly changed in the whole cell homogenate fraction after 1hour exposure to ethanol (n=4). (C) Western blot analysis of SGLT1 protein expression in the
BBM from control and ethanol-treated SD rats. The blots show a representative sample used for
densitometric quantification. (D) Densitometric quantification of SGLT1 protein expression was
not significantly altered in the BBM fraction after 1-hour exposure of ethanol (n=4). The error
bars represent the SEM. Blots were normalized with an anti-ezrin antibody to assure equivalence
of loading. All control and ethanol-treated samples were run on the same membrane.
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Figure 25: An oral gavage of ethanol in SD rats did not change SGLT1 or Na-K-ATPase
expression. (A) SGLT1 and Na-K-ATPase expression in SD rats after exposure to 1-hour of
ethanol. The blue stain represents DAPI, the green stain represents SGLT1 and the red stain
represents the Na-K-ATPase. SGLT1 is localized to the apical side, or BBM, of the cell while
the Na-K-ATPase is localized to the BLM. (B) One hour of ethanol did not significantly change
SGLT1 immunofluorescence intensity in SD rats (n=4). (C) One hour of ethanol did not
significantly change Na-K-ATPase immunofluorescence intensity in SD rats (n=4). Each sample
is an average of at least 5 different images obtained using a 20X objective. The error bars
represent the SEM.
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Discussion
Previous studies investigating the effect of ethanol on nutrition showed that ethanol could
decrease the absorption of a wide variety of vitamins (Bode and Bode 2003). Similar to our
study, others have also investigated the effect of ethanol on vitamin absorption at the level of
their respective co-transporters (Hoyumpa, Breen et al. 1975, Romanoff, Ross et al. 2007,
Subramanya, Subramanian et al. 2010, Guo, Wang et al. 2013, Subramanian, Subramanya et al.
2013). While there have been studies pertaining to nutrition and ethanol, no other study has
investigated the effect of moderate ethanol on the sodium-dependent glucose co-transporter
SGLT1 in vitro and in vivo. SGLT1 is important because it transports glucose, an essential
nutrient for intestinal cell and whole-body metabolism. Thus, the goal of this study was to
investigate the effect of a moderate dose of ethanol, equivalent to a BAC of 0.04%, on Nadependent glucose absorption in enterocytes in vitro and in vivo.
Studies conducted using the same dosage of moderate ethanol (8.64 mM) in neuronal-like
pheochromocytomas cells showed no cell death after 12 hours of continuous ethanol exposure
(Luo, West et al. 1999). This directly supports our cell viability results using an LDH assay and
trypan blue exclusion. This moderate dosage of ethanol did not significantly alter cell viability in
IEC-18 cells.
This study showed that moderate ethanol affects glucose assimilation via SGLT1 in
intestinal epithelial cells. When exposed to a moderate dose of ethanol both in vitro and in vivo,
the effects of ethanol on SGLT1 are comparable. Previous studies conducted using inverted
intestinal sacs showed that an extremely high dosage of ethanol (450 mM) decreased glucose
absorption in the jejunum of hamsters (Dinda, Beck et al. 1975, Dinda and Beck 1977). This
study did not determine if SGLT1 was specifically affected by ethanol, but the researchers
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hypothesized that there is most likely interference of glucose absorption at the co-transporter
level, which directly supports our findings.
Moreover, the present study determined that there was a decrease in the Na-K-ATPase
activity in vitro and in vivo from moderate alcohol. Other studies have investigated the effect of
ethanol upon the Na-K-ATPase activity in hepatocyte and renal cells at concentrations equivalent
to a BAC of 0.08% or above and found that acute ethanol does decrease the activity of the Na-KATPase in these organs as well (Pascale, Daino et al. 1989, Rodrigo, Novoa et al. 1996).
However, a previous study conducted with an extremely high dosage of ethanol (450 mM) in the
jejunum of hamsters did not find a change in Na-K-ATPase activity (Dinda, Beck et al. 1975).
This differs from our results. It is possible that the difference between this previous study and
our results stems from the differences in species, the duration of ethanol exposure and
concentration used. Moreover, studies conducted afterward in the jejunum of hamsters showed
that acute dosages of ethanol decreased the activity of the Na-K-ATPase (Hoyumpa, Patwardhan
et al. 1981), which does support our findings.
This decrease in Na-K-ATPase activity results in an altered sodium gradient in response
to moderate ethanol both in vitro and in vivo. Thus, at least part of the inhibition of Na-glucose
co-transport at the cellular level was secondary to this altered Na-extrusion capacity of the cell.
The degree to which the Na-K-ATPase is responsible for the inhibition of glucose absorption can
be further investigated. However, was the sodium-dependent glucose co-transporter SGLT1
directly affected? Thus, BBMV studies were undertaken. Again, moderate ethanol reduced Naglucose co-transport in BBMVs prepared from ethanol-treated SD rats. Therefore, there are two
mechanisms occurring in response to ethanol: there is a decrease in sodium-dependent glucose
absorption through SGLT1 at the level of the co-transporter itself as well as at the level of the
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sodium gradient produced by the Na-K-ATPase. Previous studies examining the effect of ethanol
on glucose absorption in BBMVs have found that direct incubation of the BBMVs with 4% v/v
ethanol reduced the absorption of glucose, as in our studies (al-Balool and Debnam 1989).
We determined that moderate ethanol does not affect the protein expression of the
SGLT1 at the whole cell homogenate and BBM levels. The effect of ethanol on protein
expression of SGLT1 has not been previously shown in the literature. Ethanol has been shown to
increase the protein expression of the vitamin C co-transporters in the intestine in response to a
25% ethanol diet for two weeks in Kunming mice (Guo, Wang et al. 2013). On the other hand,
thiamine transporter-1 protein and mRNA expression levels were decreased in response to two
through six weeks of ethanol (Subramanya, Subramanian et al. 2010). Clearly, then, moderate
ethanol’s effect on SGLT1 is secondary to the altered affinity of the sodium-dependent glucose
co-transporter as compared to diminished protein levels in the affected cells. Changes in
phosphorylation and/or glycosylation may affect the affinity of SGLT1. Indeed, it has previously
been shown that constitutive nitric oxide reduces SGLT1’s affinity for glucose by altering the
glycosylation of the protein (Arthur, Coon et al. 2014).
Conclusions
Many prior studies have determined the effect of large doses of ethanol on a variety of
gastrointestinal functions. However, these studies have not investigated the effect of a moderate
dose of ethanol. In this study, we used a moderate dose of ethanol equivalent to a BAC of 0.04%,
which is achieved monthly by most of the population of the United States, making this dose very
relevant (NIAAA). Clearly, this study demonstrates that even a modest dose of ethanol can have
significant effects on important nutrient assimilation in the mammalian intestine. Moderate
consumption of ethanol inhibits intestinal glucose assimilation. It specifically inhibits SGLT1.
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The mechanism of inhibition is secondary to the reduced affinity of SGLT1 for glucose without a
change in the number of co-transporters in enterocytes. These observations are similar both in
vitro and in vivo. In conclusion, this novel study, using a moderate dose of ethanol, describes a
possible mechanism for the malnutrition commonly seen in chronic alcoholics and thus has
potential implications for the treatment of moderate ethanol-dependent malnutrition.
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CHAPTER 6
In these studies, we were able to establish that moderate ethanol has a clear effect on the
sodium-dependent glutamine and glucose, via B0AT1 and SGLT1, co-transport, respectively, in
intestinal epithelial cells. However, we also showed that moderate ethanol affects a variety of
other cell functions, which is in part explored in this chapter.
FUNCTION OF THE NA-K-ATPASE IN REPONSE TO MODERATE ETHANOL
We determined in our previous studies that moderate ethanol significantly inhibited the
activity of the Na-K-ATPase. This assay describes the activity of the Na-K-ATPase through
inorganic phosphate release. Therefore, to also understand if the exchange of potassium ions, or
function, of the Na-K-ATPase was also affected, we conducted rubidium uptakes in IEC-18 cells
exposed to one and twelve hours of moderate ethanol. We determined that ethanol significantly
decreased 86Rb uptake in ethanol-treated cells at both time points (Figure 26; 1070±10.1
pmol/mg protein•min in controls vs 603±122 in ethanol-treated cells at 1-hour, p<0.05, n=3).
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Figure 26: One and twelve hours of moderate ethanol significantly reduced 86rubidium
uptake in IEC-18 cells (*, p<0.05, n=3). Error bars represent the SEM (1H: p<0.05; 12H:
p<0.01).
Therefore, moderate ethanol affects the Na-K-ATPase in two ways: by a decrease in the
release of inorganic phosphate as well as a decrease in the uptake of potassium ions, as measured
with the rubidium uptakes. Further experiments were conducted examining the protein
expression of the α1 subunit in response to moderate ethanol.
Immunofluorescence intensity of the Na-K-ATPase in response to moderate ethanol
This large drop in Na-K-ATPase activity could be due to many mechanisms. Previous
studies have shown that the activity and expression of the Na-K-ATPase can be affected by
ethanol (Hoyumpa, Patwardhan et al. 1981, Johnson and Crider 1989, Pascale, Daino et al. 1989,
Rodrigo, Vergara et al. 1991, Rodrigo, Novoa et al. 1996, Rodrigo and Thielemann 1997, Otis,
Mitchell et al. 2008, Rasic-Markovic, Krstic et al. 2008). Using ICC, ethanol significantly and
slightly decreased the immunofluorescence intensity of the Na-K-ATPase α-1 subunit in IEC-18
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cells (Figure 27, p<0.05, n=4). The methodology was the same as described in chapter four.
Primary antibody raised in mouse (Sigma-Aldrich 05-369) and the appropriate anti-mouse
AlexaFluor 488 secondary antibodies were used (ThermoFisher A28175).

Figure 27: Moderate ethanol decreased immunofluorescence intensity of the Na-K-ATPase
α-1 subunit in IEC-18 cells (*, p<0.05, n=4). Each sample is an average of at least 5 different
images obtained using a 20X objective. Error bars represent the SEM.

Further studies should be conducted to fully understand the effect of moderate ethanol on
the protein expression of the Na-K-ATPase.
Ethanol’s effect on ZO-1 expression
In order to determine alternative possible mechanisms of ethanol’s action on intestinal
epithelial cells, the tight junction protein ZO-1 was examined using ICC in IEC-18 cells exposed
to one and twelve hours of moderate ethanol. As ethanol has been shown to affect tight junctions,
it was important to determine if there were any changes in ZO-1 expression (Cresci, Bush et al.
2014, Elamin, Masclee et al. 2014). Moderate ethanol did not change the expression of ZO-1
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(Figure 28; p>0.05, n=4). The methodology used was described in chapter four. The primary
antibody was raised in mouse (ThermoFisher 33-9100) and the appropriate anti-mouse
AlexaFluor 488 secondary antibodies were used (ThermoFisher A28175).

Figure 28: Ethanol did not alter ZO-1 immunofluorescence intensity in IEC-18 cells (n=4).
Each sample is an average of at least 5 different images obtained using a 20X objective. Error
bars represent the SEM (1H: p>0.05; 12H: p>0.05).

Clearly, moderate ethanol does not significantly affect the tight junction protein ZO-1.
Furthermore, the passive movement of glutamine and glucose were measured in all uptake
experiments. No significant differences existed in the passive movement of glutamine and
glucose between control and ethanol-treated cells at one hour (Figure 29A; 366±44.1 pmol/mg
protein•min in controls vs 383±43.3 in ethanol-treated cells for glutamine uptake, p>0.05, n=6)
(Figure 29B; 1119±175 pmol/mg protein•min in controls vs 1086±146 in ethanol-treated cells for
glucose uptake, p>0.05, n=6). Therefore, moderate ethanol does not have a significant effect on
the passive movement of nutrients in IEC-18 cells.
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Figure 29: Moderate ethanol does not change passive nutrient uptake in IEC-18 cells. A)
Passive glutamine uptake in response to moderate ethanol for 1-hour (p>0.05, n=6). B) Passive
glucose uptake in response to moderate ethanol for 1-hour (n=6). Error bars represent the SEM.

Conclusions
Overall, this dissertation has clearly shown that moderate ethanol decreases sodiumdependent glutamine and glucose co-transport through B0AT1 and SGLT1, respectively, in
intestinal epithelial cells along the small intestine both in vitro and in vivo. Furthermore, the
work examined in this dissertation has revealed a novel and broad field of investigation for
future studies in other nutrient transporters in response to moderate ethanol along the small
intestine.
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CHAPTER 7
DISCUSSION
The small intestine is responsible for absorbing all the essential dietary nutrients the
mammalian body requires to efficiently function. The small intestine interacts with a wide
variety of ingested substances, including alcohol. Alcohol interacts with the small intestine in
almost 90% of the population of the United States at some point (NIAAA). However, the
interaction between alcohol and the absorption of nutrients along the small intestine at the level
of the nutrient co-transporter has not been fully investigated. More specifically, further research
is required to understand how moderate ethanol affects the small intestine’s two primary fuel
sources: glutamine and glucose. Therefore, this dissertation focused on the effect of moderate
ethanol on the sodium-dependent glutamine and glucose co-transporters B0AT1 and SGLT1,
respectively, in the small intestine.
Novelty and rationale
This dissertation is striking, due to the inherent novelty of the subject matter. For over
fifty years, the relationship between ethanol and nutrition has been heavily scrutinized. However,
because so much of the research focusing on ethanol’s effect on nutrient absorption was
conducted in the late 1900s, the advent of new technologies and discoveries of novel nutrient cotransporters has opened this field to new avenues of research, including the effect of ethanol on
the sodium-dependent nutrient co-transporters B0AT1 and SGLT1. This new connection
between ethanol and nutrient co-transporters is fascinating because it demonstrates ethanol’s
influence at a subcellular level.
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The novelty of ethanol and glutamine research
The association between alcohol use and glutamine absorption has never been
investigated in the mammalian system. As most ethanol and nutrition research occurred in the
late 1900s, this lack of research could be due to the delayed onset of glutamine-associated
research. The importance of glutamine in the intestinal epithelium has only been emphasized
since the early 2000s. In 2002, glutamine deprivation in rat pups displayed villus blunting in the
ileum and decreased epithelial junctions (Potsic, Holliday et al. 2002). As of 2015, researchers
were still clarifying this relationship. Researchers showed that glutamine deprivation reduced
porcine intestinal epithelial cell numbers within eight hours (Zhu, Lin et al. 2015). Clearly,
glutamine is an essential nutrient in the small intestine, but this connection was not discovered
until the past twenty years. As a result, the effect of ethanol on glutamine absorption has not yet
been investigated.
The novelty of ethanol and glucose research
On the other hand, the association between decreased glucose absorption and alcohol use
has been well investigated since the 1980s (Dinda, Beck et al. 1975, Dinda and Beck 1977,
Dinda and Beck 1981, Cobb, Van Thiel et al. 1983, al-Balool and Debnam 1989, Money,
Petroianu et al. 1990, Kaur, Kaur et al. 1995, Bode and Bode 2003, Yunus, Awad et al. 2011).
However, the SGLT1 co-transporter was not characterized until 1987 (Hediger, Coady et al.
1987) Thus, the relationship between moderate ethanol and the specific sodium-dependent
SGLT1 co-transporter in the small intestine has not been investigated until now.
The use of moderate ethanol
The dosage of ethanol was highly considered before conducting this dissertation.
Commonly, research studies use doses of ethanol that can be rarely achieved by an average adult
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(greater than a BAC of 0.2%). Levels of lethal BAC were measured in 175 adults and was
averaged to be 0.355% (Heatley and Crane 1990). However, despite this being the lethal limit of
alcohol consumption, some studies have used this high concentration of alcohol (Hoyumpa,
Breen et al. 1975, Dinda and Beck 1977, Lemos, Azevedo et al. 2005, Romanoff, Ross et al.
2007, Li, Xu et al. 2008). Other studies focus on more relatable doses, achieved by chronic
alcoholics (Hoyumpa, Breen et al. 1975, Hajjar, Tomicic et al. 1981, Hoyumpa, Patwardhan et
al. 1981, Antonson and Vanderhoof 1983, Pascale, Daino et al. 1989, Rodrigo, Vergara et al.
1991, Kaur, Kaur et al. 1995, Rodrigo, Novoa et al. 1996, Rodrigo and Thielemann 1997, Otis,
Mitchell et al. 2008, Joshi, Mehta et al. 2009, Sabino, Petroianu et al. 2010, Subramanya,
Subramanian et al. 2010, Nogales, Ojeda et al. 2011, Guo, Wang et al. 2013, Subramanian,
Subramanya et al. 2013). Few studies use doses lower than that seen in chronic alcoholics
(Krishnamra and Limlomwongse 1987, Hamid, Wani et al. 2007). Therefore, we chose to use a
dosage of ethanol that is achieved not only by chronic alcoholics, but by moderate drinkers: a
BAC of 0.04%. This dosage of moderate ethanol is achieved by over half of the population of the
United States per month. Therefore, our dosage used was considered very translational to the
human condition (NIAAA, Gunzerath, Faden et al. 2004).
Ethanol, B0AT1 and SGLT1
The absence of research conducted directly on the B0AT1 and SGLT1 co-transporters in
the intestinal ileum using a moderate dosage of ethanol allows this dissertation to stand alone in
the field of alcohol and nutrition research.
Aim
The aim of this study was to investigate the effect of moderate ethanol on the sodiumdependent glutamine and glucose co-transporters in the small intestine: B0AT1 and SGLT1,
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respectively. We demonstrated these findings in the ileum of the small intestine, due to its
compensatory mechanisms of nutrient absorption. If ethanol affects nutrient absorption at the
ileum, it is likely that transport is affected throughout the intestine (Koopmans 1990). In order to
accomplish this goal, we began by testing the effect of ethanol on nutrient absorption in a rat
intestinal epithelial cell line (IEC-18).
In vitro experimentation
Preliminary data
Dosage
The initial steps of this dissertation involved establishing the dose of ethanol to use. Even
sub-moderate doses of ethanol (0.02% BAC) significantly decreased the absorption of glutamine
in IEC-18 cells. This is the dosage equivalent of less than a standard alcoholic beverage for
women and one alcoholic beverage for men. Few studies have seen a physiological effect on
nutrient co-transport at this small amount of ethanol with one of the few being conducted by
Krishnamra and colleagues (Krishnamra and Limlomwongse 1987, Hamid, Wani et al. 2007).
Most studies are conducted with chronic doses of ethanol (Dinda, Beck et al. 1975, Dinda and
Beck 1977, Beck and Dinda 1981, Dinda and Beck 1981, Hajjar, Tomicic et al. 1981, al-Balool
and Debnam 1989, Kaur, Kaur et al. 1995, Li, Xu et al. 2008, Sabino, Petroianu et al. 2010,
Subramanya, Subramanian et al. 2010, Guo, Wang et al. 2013, Subramanian, Subramanya et al.
2013). In all, the dosage equivalent of a 0.04% BAC was selected due to its translational
applicability in humans, as it is the equivalent of a moderate dosage of ethanol.
Cell viability
The next logical step in our investigation of ethanol on nutrient absorption was to assess
if this dosage of ethanol could harm intestinal epithelial cells. A study conducted in neuronal-like
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pheochromocytoma (PC12) cells, using the same dosage of ethanol used in our studies (0.04%
BAC), showed that ethanol caused cell death after consistent exposure for 24 hours using trypan
blue assays (Luo, West et al. 1999). Using trypan blue and LDH assays, we determined that there
was no change in cell viability in response to this dosage of ethanol over one to twelve hours in
IEC-18 cells, similar to previous studies (Luo, West et al. 1999).
BLM versus BBM treatment
As ethanol has been shown to interact with the ileum of the small intestine along the
BLM of the cell, through the vasculature, the effect of ethanol on the BLM was conducted using
transwell studies. The effect of moderate ethanol on glutamine uptake was the same whether
treated on the BLM side or the BBM. Therefore, studies were conducted using apical treatment
to reduce significant time and fiscal cost.
Acetaldehyde
We also assessed the action of ethanol’s primary toxic metabolite, acetaldehyde, as a
possible mechanism of this decrease in nutrient absorption. One study has shown that
acetaldehyde can mediate decreased folate absorption in the colon of chronic ethanoladministered rats. The decreased folate absorption was reversed with the administration of 50
mg/kg ciprofloxacin, which decreased the proliferation of bacteria in the colon, and therefore the
inherent acetaldehyde production (Homann, Tillonen et al. 2000). Therefore, it is important to
always consider the effect of the primary metabolite of ethanol metabolism and its potential
effects on nutrient absorption.
We measured 11.4 µM acetaldehyde after one hour of moderate ethanol exposure in IEC18 cells. Other studies have found comparable amounts of acetaldehyde in the small intestine.
One study using wildtype mice found plasma ethanol levels equivalent to approximately 0.6 g/dL
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ethanol led to approximately 15 µM excess acetaldehyde in ethanol-treated mice. This directly
supports the acetaldehyde concentrations used in our studies (Chaudhry, Samak et al. 2015).
Further studies in the upper small intestine of Wistar rats show that concentrations of
acetaldehyde can reach approximately 7.9 µM, but in response to 34 mM ethanol. This is
significantly higher than the concentration used in our studies, but the values may vary due to the
influence of the liver in this study compared to our in vitro experiment as well as intestinal
segment differences (Chaudhry, Samak et al. 2015).
Therefore, we administered 15 µM acetaldehyde to IEC-18 cells for one hour and found
that both glutamine and glucose absorption was unaffected by this dosage of acetaldehyde. Thus,
ethanol, not its primary toxic metabolite acetaldehyde, is causing the decrease in nutrient
absorption in these cells.
Ethanol’s effect on glutamine absorption in vitro
As a main finding of this dissertation, we determined that moderate ethanol significantly
decreased sodium-dependent glutamine absorption in IEC-18 cells over one to twelve hours. No
other study has shown that ethanol significantly decreases sodium-dependent glutamine
absorption in the small intestine. As ethanol decreases the absorption of a variety of nutrients
along the small intestine, it was not surprising that glutamine absorption was decreased in
response to ethanol in our studies (Chang, Lewis et al. 1967, Dinda, Beck et al. 1975, Hoyumpa,
Breen et al. 1975, Dinda and Beck 1977, Racusen and Krawitt 1977, Hoyumpa 1980, Dinda and
Beck 1981, Hoyumpa, Patwardhan et al. 1981, Antonson and Vanderhoof 1983, Cobb, Van Thiel
et al. 1983, Middleton 1986, Krishnamra and Limlomwongse 1987, al-Balool and Debnam 1989,
Money, Petroianu et al. 1990, Pfeiffer, Schmidt et al. 1992, Kaur, Kaur et al. 1995, Bode and
Bode 2003, Lemos, Azevedo et al. 2005, Hamid, Wani et al. 2007, Romanoff, Ross et al. 2007,
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Li, Xu et al. 2008, Subramanya, Subramanian et al. 2010, Yunus, Awad et al. 2011, Guo, Wang
et al. 2013, Subramanian, Subramanya et al. 2013, Thakur, Rahat et al. 2015). However, few
studies have investigated ethanol’s effect on the individual nutrient co-transporters along the
small intestine, with none in an ileal cell line (Hamid, Wani et al. 2007, Li, Xu et al. 2008, Joshi,
Mehta et al. 2009, Subramanya, Subramanian et al. 2010, Nogales, Ojeda et al. 2011, Guo, Wang
et al. 2013, Subramanian, Subramanya et al. 2013, Thakur, Rahat et al. 2015). We determined
that ethanol decreased the maximal velocity of the sodium-dependent B0AT1 co-transporter
(Vmax) without a change in the affinity of the co-transporter (Km), suggesting that the number of
B0AT1 co-transporters was decreased. We determined that moderate ethanol did decrease
B0AT1 protein expression at the whole cell homogenate and BBM, explaining this decrease in
Vmax values. Few other studies have demonstrated a change in the kinetic parameters of a cotransporter in response to ethanol (Kaur, Kaur et al. 1995, Hamid, Wani et al. 2007, Nogales,
Ojeda et al. 2011). Previous studies have shown that B0AT1 is decreased in response to chronic
intestinal inflammation in the rabbit ileum (Saha, Arthur et al. 2012). Chronic intestinal
inflammation also decreased the Vmax values for B0AT1, without a change in affinity (Km).
Overall, in response to intestinal stressors such as moderate ethanol and chronic intestinal
inflammation, sodium-dependent glutamine co-transport is decreased.
Furthermore, changes of protein co-transporter levels in response to ethanol have been
shown before as well, but never for B0AT1 (Joshi, Mehta et al. 2009, Subramanya, Subramanian
et al. 2010, Guo, Wang et al. 2013, Subramanian, Subramanya et al. 2013, Thakur, Rahat et al.
2015). Overall, moderate ethanol decreased B0AT1 protein expression at the BBM, leading to
decreased glutamine absorption in IEC-18 cells.

113

Ethanol’s effect on glucose absorption in vitro
At this point, it was important to consider if moderate ethanol could affect other sodiumdependent nutrient co-transporters. Therefore, another sodium-dependent nutrient co-transporter
was tested: SGLT1. Previously, there was a lot of background information on ethanol and
glucose absorption (Dinda, Beck et al. 1975, Dinda and Beck 1977, Dinda and Beck 1981, Cobb,
Van Thiel et al. 1983, al-Balool and Debnam 1989, Money, Petroianu et al. 1990, Kaur, Kaur et
al. 1995, Yunus, Awad et al. 2011), but no other studies have been conducted using moderate
ethanol in the ileum of the small intestine. We determined that sodium-dependent glucose cotransport was also decreased in response to ethanol, as described in the previous studies (Dinda,
Beck et al. 1975, Dinda and Beck 1977, Dinda and Beck 1981, Cobb, Van Thiel et al. 1983, alBalool and Debnam 1989, Money, Petroianu et al. 1990, Kaur, Kaur et al. 1995, Yunus, Awad et
al. 2011). Furthermore, kinetic studies showed increased Km values, suggesting a decrease in the
affinity of the glucose co-transporter to its substrate. There was no change in Vmax values, which
was subsequently supported with no changes to SGLT1 protein expression in the whole cell
homogenate and BBM, as seen in Western blots. Previous studies have shown decreases in the
affinity of nutrient co-transporters in response to ethanol as well (Hamid, Wani et al. 2007,
Nogales, Ojeda et al. 2011). Another study investigating glucose absorption found no change in
Km values, but a decrease in Vmax values in response to ethanol. The difference between this study
and our results could be due to the difference in ethanol concentration used between these studies
(20% v/v ethanol for 40 days in rats) (Kaur, Kaur et al. 1995). No other study has reported
changes to SGLT1 protein expression in response to any dose of ethanol. Overall, we
demonstrated that ethanol does not only inhibit sodium-dependent B0AT1 co-transport in the
small intestine, but also sodium-dependent SGLT1 co-transport as well.
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Ethanol’s effect on Na/H exchange in vitro
This change in SGLT1-mediated glucose absorption at the level of the co-transporter was
fascinating. But it brought up a very important question: is this a system-wide inhibition of all
sodium absorptive processes in the intestinal BBM? This hypothesis was fathomable due to
ethanol’s inhibitory effect on the sodium-gradient (Hoyumpa, Patwardhan et al. 1981, Rodrigo,
Vergara et al. 1991, Rodrigo, Novoa et al. 1996, Rodrigo and Thielemann 1997). The primary
sodium absorptive pathways in intestinal epithelial cells is through SGLT1 and Na/H exchange.
Since SGLT1 has been shown to be coupled to Na/H exchange through intracellular nitric oxide
(Coon, Kekuda et al. 2008), Na/H exchange was conducted in IEC-18 cells exposed to moderate
ethanol for one hour. No change was demonstrated in Na/H exchange in response to moderate
ethanol which demonstrates that the effect of ethanol on nutrient co-transport is not a systemwide depressant of the sodium absorption processes in the small intestine. Considering that
SGLT1 and the Na/H exchanger NHE3 have previously been shown to be coupled, regulated by
constitutive nitric oxide in rabbit intestinal epithelial cells (Coon, Kekuda et al. 2008), it was
surprising to see that Na/H exchange was also not affected by moderate ethanol. However, recent
studies have demonstrated that Na/H exchange is not always affected in conjunction with SGLT1
(Manoharan, Sundaram et al. 2018). Researchers demonstrated a decrease in SGLT1 activity in
response to chronic intestinal inflammation, but not in Na/H exchange. Therefore, it is
reasonable to accept that SGLT1 can be affected by ethanol, without a change in Na/H exchange
(Manoharan, Sundaram et al. 2018).
In vivo experimentation
Ethanol use, even at a moderate dose, has whole body effects due to its transit through the
vasculature (Bode and Bode 2003, Krenz and Korthuis 2012). In order to provide a more
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convincing translational study, involving the enteric, vascular, and muscular systems, an in vivo
model was used. Despite these added variables, the inhibitory effect of moderate ethanol on
sodium-dependent glucose co-transport was still observed in Sprague Dawley rats administered
an intragastric gavage of 2 g/kg ethanol (equivalent to a BAC of 0.04%). Na-K-ATPase activity
and glucose absorption were both suppressed in vivo as in the in vitro model. Furthermore,
similar results were demonstrated in kinetic studies, Western blots, and immunohistochemistry in
vivo as in vitro. These similar results in vivo and in vitro only help to demonstrate the
translational applicability of the effect of ethanol on nutrient absorption in the small intestine.
Furthermore, in the in vivo model, BBMV uptake experiments were able to be prepared
from control and ethanol-treated rats. BBMVs separate the BLM-located Na-K-ATPase from the
apical BBM. Resulting nutrient uptakes showed that glucose absorption was still inhibited in
response to moderate ethanol without the influence of the Na-K-ATPase. Overall, this
demonstrates that ethanol specifically affects the nutrient co-transporter itself, in addition to its
effect on the sodium gradient. BBMVs were also used in studies examining the effect of ethanol
on glucose absorption in the jejunum of hamsters and Sprague Dawley rats (Dinda and Beck
1981, al-Balool and Debnam 1989). However, these studies administered the respective dosages
of ethanol directly onto the vesicles, whereas our studies did not. Overall, all of these studies
using BBMV uptakes found that ethanol directly inhibits glucose absorption at the co-transporter
itself without the influence of the Na-K-ATPase.
Additional experiments
The effect of ethanol on the Na-K-ATPase
The effect of ethanol on the BLM Na-K-ATPase needed to be investigated if we were to
completely understand the effect of ethanol on the BBM-located nutrient co-transporters. We
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found that the decrease in Na-K-ATPase activity was inhibited by more than half of its normal
activity levels. This was an immense inhibition. However, similar inhibitions of Na-K-ATPase
activity have been demonstrated in previous studies. For example, binding of the Na-K-ATPase
regulatory protein phospholemman reduces Na-K-ATPase activity by approximately 40%
(Mishra, Habeck et al. 2015). Phosphorylation of this protein by PKC can affect the function of
this pump, but only the α-2 isoform in Xenopus llaevis oocytes (Bibert, Roy et al. 2008).
Moreover, the Na-K-ATPase can experience approximately a 60% drop at 20 mmol/L sodium
when exposed to 2 mmol/L oxidized glutathione in the human skeletal muscle (Juel, Hostrup et
al. 2015). In all, the large drop in Na-K-ATPase activity has been shown multiple times
throughout the literature (Bibert, Roy et al. 2008, Juel, Hostrup et al. 2015, Mishra, Habeck et al.
2015).
We demonstrated similar inhibition of Na-K-ATPase activity in vivo in response to
moderate ethanol. The assay used to analyze Na-K-ATPase activity was via inorganic phosphate
release. This pump requires the hydrolysis of ATP to function, making inorganic phosphate
release a very reasonable measurement of Na-K-ATPase activity. However, the Na-K-ATPase
also maintains important concentration gradients in cells by exchanging three sodium ions out of
the cell for two potassium ions into the cell. Moderate ethanol may also be affecting this
important function of the Na-K-ATPase. Therefore, we measured the function of the Na-KATPase using rubidium uptakes, which approximately measures how much potassium the Na-KATPase is transporting into the cell. We established that moderate ethanol significantly
decreased uptake of rubidium in IEC-18 cells. Therefore, moderate ethanol also significantly
inhibits the functional activity of the Na-K-ATPase in IEC-18 cells.
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However, how is the function and activity of the Na-K-ATPase affected by moderate
ethanol? We found that there was a significant decrease in the immunofluorescence intensity of
the Na-K-ATPase α-1 subunit in IEC-18 cells exposed to moderate ethanol for one hour. This
decrease in immunofluorescent intensity could explain the decrease in activity. The Na-KATPase has been previously shown to be altered in intestinal epithelial cells. In intestinal
epithelial cells of chronically inflamed rabbits, the activity of the Na-K-ATPase was decreased,
but was not due to changes in protein expression or relative mRNA abundance of the α-1 and β-1
subunits (Saha, Manoharan et al. 2015). It was suggested that ankyrin, part of the protein
cytoskeleton necessary for the correct trafficking of the Na-K-ATPase, was affected by chronic
intestinal inflammation. Ankyrin protein expression was significantly diminished in intestinal
epithelial cells, which resulted in improper trafficking to the BLM, and the decrease in Na-KATPase activity (Saha, Manoharan et al. 2015). Clearly, the Na-K-ATPase can be affected by
improper trafficking. Moreover, activation of the Na-K-ATPase-associated Src kinase has been
shown to induce endocytosis of the Na-K-ATPase (Xie and Xie 2005). Further research is
necessary to fully understand the effect of ethanol on the Na-K-ATPase.
Effect of moderate ethanol on ZO-1 expression
Possible mechanisms of this decrease in nutrient absorption could be due to the integrity
of the tight junctions in these intestinal epithelial cells. Fortunately, the glutamine and glucose
uptake studies conducted in intestinal epithelial cells account for the passive movement of
glutamine and glucose into the intestinal epithelial cells. There was no significant difference in
the passive movement of these nutrients in response to moderate ethanol. However, it has been
demonstrated that intestinal epithelial cells can have alterations to their transmembrane proteins,
like tight junctions, in response to ethanol (Cresci, Bush et al. 2014, Elamin, Masclee et al.
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2014). Therefore, in IEC-18 cells, ZO-1 immunofluorescence intensity was examined. ZO-1
immunofluorescence intensity was not significantly changed in response to one and twelve hours
of moderate ethanol. Although this does not fully describe the localization of this tight junction
protein, as the protein could be translocated intracellularly, future studies examining this
phenomenon can elucidate if this dosage of moderate ethanol removes tight junction proteins like
ZO-1 from the cellular junctions and studies measuring transepithelial resistance can ensure the
stability of the intestinal tight junctions.
Possible mechanisms
Ethanol-mediated decrease in glutamine absorption in vitro
It is quite clear that moderate ethanol decreases glutamine absorption at the level of the
sodium-dependent glutamine co-transporter in response to a moderate dosage of ethanol. We
demonstrated in IEC-18 cells that moderate ethanol decreased the protein expression of B0AT1
in whole cell homogenates and BBM, concurrently with a visible decrease in
immunofluorescence intensity. Clearly, ethanol is causing a removal of B0AT1 protein
expression from the BBM, which is supported by our kinetic studies demonstrating a decrease in
Vmax values. Previous studies in our lab have demonstrated that B0AT1 is also inhibited through
a reduction in BBM co-transporters during states of chronic intestinal inflammation (Saha,
Arthur et al. 2012). Researchers demonstrated that inducible nitric oxide, which is elevated
during chronic intestinal inflammation, regulates the inhibition of B0AT1 at the BBM of rabbit
intestinal villus cells. This was demonstrated through use of an inducible nitric oxide inhibitor,
L-NIL, which reversed the inhibition of B0AT1 (Arthur and Sundaram 2015). This reversal was
also shown through administration of the glucocorticoids (Arthur, Saha et al. 2012) via
prostaglandins in the cyclooxygenase pathways (Arthur, Singh et al. 2018). Overall, B0AT1 has
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also been shown to be removed from the BBM under states of chronic intestinal inflammation,
due to immune system modulators, which may be similar to what is occurring in our study
regarding ethanol. Ethanol could be causing signaling cascades that could lead to the removal of
B0AT1 from the BBM.
One of these signaling cascades could be initiated by PKC. In PKC siRNA studies
conducted in IEC-18 cells, the inhibitory effect on glutamine absorption was reversed. Although
this is only one of many possible mechanisms, clearly PKC has an effect on glutamine
absorption in response to moderate ethanol. Further studies are needed to describe this
mechanism.
Ethanol-mediated decrease in glucose absorption in vitro and in vivo
Ethanol also causes a decrease in sodium-dependent glucose co-transport in vitro and in
vivo; however, moderate ethanol differentially regulates B0AT1 and SGLT1. The mechanism of
moderate ethanol on SGLT1 is through increased Km values, suggesting a decrease in the
affinity of the co-transporter to its substrate.
The change in affinity of SGLT1 in response to moderate ethanol could be caused by
post-translational modifications of SGLT1. SGLT1 has been shown to be phosphorylated or
glycosylated in response to cell mediators (Arthur, Coon et al. 2014). In previous studies,
inhibition of constitutive nitric oxide has shown an inhibition of SGLT1 through a reduction in
the affinity in IEC-18 cells, which was shown to be due to the glycosylation of SGLT1 (Arthur,
Coon et al. 2014). Ethanol could be initiating signaling mechanisms which could activate posttranslational modifications of SGLT1, causing this decrease in SGLT1-mediated glucose
absorption in response to moderate ethanol. Further research is necessary to explore this
hypothesis.
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FUTURE DIRECTIONS
The signaling mechanisms causing these differing effects on glutamine and glucose
absorption in intestinal epithelial cells can be elucidated in the future. Previous studies have
found that B0AT1 and SGLT1 can be affected by different signaling mechanisms (Arthur, Coon
et al. 2014, Arthur, Singh et al. 2018). Furthermore, the mechanism of action of ethanol on the
Na-K-ATPase in intestinal epithelial cells has yet to be clarified. Future studies can focus on
determining ethanol’s effect on the necessary sodium-gradient for sodium-dependent cotransporters.
Ethanol influences nutrient absorption along the small intestine (Chang, Lewis et al.
1967, Dinda, Beck et al. 1975, Hoyumpa, Breen et al. 1975, Dinda and Beck 1977, Racusen and
Krawitt 1977, Hoyumpa 1980, Dinda and Beck 1981, Hoyumpa, Patwardhan et al. 1981,
Antonson and Vanderhoof 1983, Cobb, Van Thiel et al. 1983, Middleton 1986, Krishnamra and
Limlomwongse 1987, al-Balool and Debnam 1989, Money, Petroianu et al. 1990, Pfeiffer,
Schmidt et al. 1992, Kaur, Kaur et al. 1995, Bode and Bode 2003, Lemos, Azevedo et al. 2005,
Hamid, Wani et al. 2007, Romanoff, Ross et al. 2007, Li, Xu et al. 2008, Subramanya,
Subramanian et al. 2010, Yunus, Awad et al. 2011, Guo, Wang et al. 2013, Subramanian,
Subramanya et al. 2013, Thakur, Rahat et al. 2015). Chronic use of alcohol can lead to an
alcohol-dependent malnutrition that may be able to be modulated by supplementation of specific
nutrients. Supplementation with glutamine may be beneficial in cases of intestinal disruption
linked with heavy alcohol use, which may help prevent the dangerous translocation of
endotoxins seen in chronic alcoholics causing liver damage. This is a prime potential avenue for
future ethanol and glutamine research.
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Moreover, the ethanol-mediated phenomenon described in this dissertation also provides
a potential mechanism of onset for alcohol-dependent malnutrition. Future studies should
investigate potential mediators that may ameliorate this condition. Furthermore, future
investigations can explore the involvement of ethanol-dependent inhibition of glucose absorption
in order to aid in glucose-associated diseases like diabetes and obesity. Overall, there are many
potential avenues for future research in the field of ethanol and sodium-dependent nutrient cotransport.
CONCLUSIONS
We demonstrated that a moderate dosage of ethanol significantly decreased sodiumdependent glutamine and glucose co-transport in a rat intestinal epithelial cell line (IEC-18) and
that moderate ethanol decreased sodium-dependent glucose co-transport in Sprague Dawley rats.
We isolated the effect of ethanol into two separate mechanisms: at the level of the sodiumdependent nutrient co-transporters, B0AT1 and SGLT1, as well as to the sodium gradient set by
the Na-K-ATPase. Furthermore, we showed that silencing PKC in IEC-18 cells reverses the
effect of ethanol on sodium-dependent glutamine absorption which offers the first part of a
probable mechanism for ethanol’s effect on sodium-dependent glutamine absorption. Overall,
this novel dissertation defined moderate ethanol’s effect on the sodium-dependent nutrient cotransport in the small intestine. This dissertation and future experiments can help describe the
onset of alcohol-dependent malnutrition.
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APPENDIX B: ABBREVIATIONS
ADH – Alcohol dehydrogenase
ALDH – Aldehyde dehydrogenase
ATP – Adenosine triphosphate
BAC – Blood alcohol content
BBM – Brush border membrane
BBMV – Brush border membrane vesicle
BLM – Basolateral membrane
BSA – Bovine serum albumin
COX – Cyclooxygenase
cNOS – Constitutive nitric oxide synthase
CYP2E1 – Cytochrome P450 2E1
DMEM – Dulbecco’s modified Eagle’s medium
GI – Gastrointestinal
ICC – Immunocytochemistry
IEC – Intestinal epithelial cell
IHC - Immunohistochemistry
Pi – Inorganic phosphate
iNOS – Inducible nitric oxide synthase
HIF – Hypoxia inducible factor
HNF – Hepatocyte nuclear factor
HSP – Heat shock protein
NAD – Nicotinamide adenine dinucleotide
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NHE3 – N/H exchanger 3
NO – Nitric oxide
OMG – O-methyl-D-glucose
PBS – Phosphate buffered saline
PKC – Protein kinase C
PTP – Protein tyrosine phosphatase
ROS – Reactive oxygen species
SD – Sprague Dawley
SEM – Standard error of the mean
SLC – Solute carrier
TJ – Tight junction
TNF – Tumor necrosis factor
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Senior Thesis
The Effect of Ethanol on BK Channel Current and Channel Density
May 2013 - May 2014
Allegheny College, Meadville, PA
• Designed, conducted and orally defended a unique independent research project under
Dr. Lauren French
• Investigated the effect of ethanol exposure upon Xenopus laevis oocytes injected with BK
channel RNA using electrophysiology
• Fifteen minutes of 50 mM ethanol exposure increased channel current by 70 percent
• Initiation of immunofluorescent experiments were conducted by expressing GFP tagged
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BK channels in order to investigate channel trafficking
Research Experience
Research Assistant to Dr. Uma Sundaram
April 2014 - Present
Marshall University Biomedical Research Program, Huntington, WV
• Established intestinal stem cell isolation and culture from mouse, rabbit and human
samples
• Conducted general laboratory procedures including Western blots, protein assays, RTQPCR, immunocytochemistry, immunohistochemistry, cell viability assays, radioactive
whole cell uptakes, radioactive brush border membrane uptakes and radioactive kinetic
studies
• Extensively worked with various mammalian vertebrate models including B6 and TallyHo mice, lean and obese Zucker rats, Sprague Dawley rats, and New Zealand White
rabbits as well as with cell culture lines such as human epithelial colorectal
adenocarcinoma cells (Caco2), intestinal epithelial cells (IEC-18), human embryonic
kidney super topflash assay cells (HEK293-STF), R-spondin2 and Wnt3A producing
cells lines
• Specialized in unique laboratory procedures including intestinal brush border membrane
isolation, plasma membrane isolation, intestinal crypt and villus isolation in mice, rats
and rabbits, oral gavage in rats and rabbits, reactive oxygen species assays, acetaldehyde
assays and Na/K-ATPase assays
Research Rotations
August 2014 - May 2015
Marshall University Biomedical Research Program, Huntington, WV
• Conducted four different laboratory rotations averaging 120 hours each
• Gained experience in general laboratory procedures including protein assays, Western
blot techniques, cell culture, molecular biology procedures, mammalian animal
experimentation, ELISA, hippocampal slice isolation, field potential recording and
radioactive uptake experimentation
Research Assistant to Dr. Lauren French
May 2013 - April 2014
Allegheny College, Meadville, PA
• Gained experience in general laboratory procedures, electrophysiology, non-mammalian
vertebrate experimentation and molecular biology procedures
• Generated BK channel RNA using Northern blot, DNA and RNA isolation techniques
• Conducted recoverable surgeries with the non-mammalian model Zenopus laevis frogs
and injected RNA using a nanoinjector into isolated Zenopus laevis oocytes
• Established electrophysiology procedures with Zenopus laevis oocytes using two
electrode voltage clamp
Grants
NASA West Virginia Space Grant Consortium
July 2018 – July 2019
• Awarded a 12,000 dollar grant to study the effect of a short and long-term dose of ethanol
in Sprague Dawley rats on glucose absorption along the small intestine
Scientific Conferences
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41st Annual Scientific Meeting of the Research Society on Alcoholism
June 2018
San Diego, CA
• Presented a poster presentation on the novel effect of ethanol on glucose absorption along
in intestinal epithelial cells among over 1,000 leading researchers in the field of
alcoholism
Digestive Diseases Week 2018
June 2018
Washington D.C.
• Presented a poster on the unique effect of ethanol on glutamine absorption in intestinal
epithelial cells among over 14,000 leading researchers studying digestive diseases
Digestive Diseases Week 2017
June 2017
Chicago, IL
• Attended the conference as a co-author on a poster describing the effect of the obesity on
the Na-K-ATPase and another poster illustrating the effect of the adipose-derived
secretome on glutamine absorption in intestinal epithelial cells
Marshall University Health Sciences Research Day
August 2014 - 2019
Marshall University Joan C. Edwards School of Medicine, Huntington, WV
• Attended as a Marshall University Biomedical Research Graduate Student to share and
discuss research conducted among colleagues at Marshall University
Presentations
31st annual Marshall University Health Sciences Research Day
March 2019
Marshall University Joan C. Edwards School of Medicine, Huntington, WV
• Delivered a 15-minute presentation on the effect of moderate ethanol on glutamine
absorption in an intestinal epithelial cell line (IEC-18)
• Awarded Best Oral Presentation
27th annual Marshall University Health Sciences Research Day
March 2016
Marshall University Joan C. Edwards School of Medicine, Huntington, WV
• Delivered a 15-minute presentation on the use of intestinal stem cells, called enteroids, as
a new model of intestinal research
Committees
Ph.D. Student Admissions Interview Committee
January – April 2017, 2019
Marshall University Biomedical Research Program, Huntington, WV
• Actively participated in the interview committee for potential incoming Ph.D. graduate
students by providing a current student perspective
Administrative Director Interview Committee
July 2018
Marshall University Biomedical Research Program, Huntington, WV
• Provided a student’s perspective during the interview process for the administrative
director for the Marshall University Research Program
Honors
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Best Oral Presentation
March 2019
Marshall University Joan C. Edwards School of Medicine, Huntington, WV
• Placed first in the basic sciences category for students during Marshall University Health
Sciences Research Day presenting on the effect of moderate ethanol on glutamine
absorption in an intestinal epithelial cell line (IEC-18)
Best Overall Performance as a Graduate Student
July 2017-2018
Marshall University Biomedical Research Program, Huntington, WV
• Awarded based on the overall research and academic performance as well as service
through the Graduate Student Organization
Poster of Distinction
June 2018
Digestive Diseases Week, Washington D.C.
• Received a Poster of Distinction award for a poster presentation on the effect of moderate
ethanol on glutamine absorption in intestinal epithelial cells
• The award is distributed only among the top ten percent of accepted poster abstracts
Graduate Student Organization Scholarship
August 2017
Marshall University Biomedical Research Program, Huntington, WV
• Received a 500 dollar scholarship from the Graduate Student Organization (GSO) based
on scholastic merit, volunteer activities, and GSO participation
Memberships
American Gastroenterological Association (AGA)
April 2018 – Present
• Hold a membership among 16,000 colleagues in the research, medical practice and
advancement of gastroenterology
Research Society on Alcoholism (RSA)
January 2018 – Present
• Maintain a membership among the leading scientists researching alcoholism and alcoholrelated diseases
Organizations and Activities
Biomedical Sciences GSO member
August 2014 - Present
• Hold a membership in the organization that represents the graduate students in the
biomedical graduate program at Marshall University and conducts various community
outreach, fundraising and volunteer activities
GSO Secretary
May 2015 – May 2017
• Meeting and board meeting notes were taken and filed appropriately
• Attending all tutoring sessions to ensure questions by first year students were
appropriately addressed
GSO President
May 2016 – May 2017
• As President, all GSO board meetings and monthly meetings were planned accordingly.
This includes managing the GSO’s paperwork, funds and representing the GSO at
Marshall University events
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•
•
•

Various fundraising activities were planned and organized including three bake sales, a
soup sale, and a t-shirt drive
Community outreach included planning and participating in the International Food
Festival, Naloxone training, creating a GSO intramural sports team, local bowling nights
as well as the Jared’s box drive and the Loose the Training Wheels program
Volunteer activities included tutoring sessions for Marshall University students and
several presentations describing how to appropriately study for graduate school

Marshall Women’s Rugby Club
August 2014 – October 2018
Huntington, WV
• Member of the Marshall Women’s Rugby Club
• Captain of the team from January 2018 through October 2018
• Initiated the first annual Prom on the Pitch fundraising match where all raised funds
were donated to the Huntington City Mission Women and Family Shelter in April 2018
Volunteer Activities
Jared’s Box
December 2014, 2015, 2016
and 2017
• Gathered, wrapped and delivered toys for children staying at the local Hoop’s Family
Children’s Hospital at Cabell Huntington Hospital and emergency room, St. Mary’s
Hospital and emergency room and the local Huntington City Mission Women and Family
Shelter over the holidays
• Orchestrated the entire drive in December 2016 in which the organization had record
donations from the graduate student organization in our area and expanded the donations
to the Huntington City Mission Women and Family Shelter and St. Mary’s Hospital
Emergency Room
• Further expanded donations to the Cabell Huntington Hospital Emergency Room and St.
Mary’s Children’s Ward in December 2017
Tutor
September 2015 – May 2017
• Tutored biomedical research students in groups ranging from 3 to 20 in various
biochemical topics and laboratory procedures before exams
• Organized tutors, locations and times for tutoring groups from September 2016 through
the May 2017
Science fair judge
December 2015
• Served as a science fair judge for the local Huntington high school
• Graded over 80 entries for their presentation skills, use of the scientific method, and
overall project

146

